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Abstract 
This study investigated a series of independent unassisted and device-assisted 
transfers from a wheelchair to vehicle mock-up and vice versa while simultaneously 
capturing kinematic, kinetic and electromyographic (EMG) data of impaired volunteers. 
The study provides a venue for observation and evaluation of upper extremity (UE) joint 
stresses, muscular force and functional demands associated with transfers in persons 
with spinal cord injury (SCI) to ultimately prevent UE injury, minimize excessive stress, 
preserve functionality and limit pain. If people with SCI lose function of their UEs, due to 
pain and/or degeneration, they must then rely on others for everyday tasks.  
Five paraplegic males from the Tampa Bay area were recruited to take part in the 
study. Participants were asked to perform a series of transfers using 4 commercially 
available devices or mock-ups of that device as well as an unassisted transfer, which 
permitted the use of no assistive device. Three data types were captured: kinematic data 
using motion capture, kinetic data using force transducers which were integrated into the 
vehicle mock-up and EMG of 5 bilateral muscle groups. Data collection took 
approximately 4 hours per subject.  
Forces occurring during the unassisted transfers were found to be the highest. 
This is also supported by the EMG data. Performing level transfers lessened stresses at 
the UE versus non-level transfers. The highest moments of the UEs were found at the 
shoulders with high variability between subjects. It was also found that body mass index 
(BMI) had an affect on a subjects ability to perform transfers. 
 Ultimately this study found that using an assistive device is better than not using 
an assistive device. This is proven by EMG and force data, which were both found to be 
 viii 
less with the use of an assistive device as opposed to transferring independently with no 
assistance. Performing level transfers, maintaining ones body mass and staying active 
are all factors that will limit stresses at the UEs during wheelchair transfers to and from a 
vehicle. 
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Chapter 1 – Introduction 
1.1 Background 
Individuals with SCI that render them paraplegics face a variety of challenges 
post-injury. Typically, people with SCI perform activities of daily living (ADLs) such as 
mobility, dressing, transferring and repositioning, without the functional use of their lower 
extremities. Since most persons with SCI are young when injured and are living 
longer,1,2 concerns are justified about maintaining independence during ADLs over time. 
Increase in knowledge of SCI has helped improved post-injury care, which in-turn 
increases the need for secondary injury prevention. 
For persons with SCI, many years of overuse of the UEs leads to an increased 
incidence of cumulative trauma to the shoulders, elbows and wrists. Over 50% of 
persons with SCI have UE pain;3 rotator cuff tears have been reported in 59-73%;4 and 
40% have clinical evidence of carpal tunnel syndrome.5 UE deterioration following years 
of compensating for the lack of functional lower extremities reduces quality of life, 
function, independence and even life expectancy following SCI.6-8 To minimize the 
adverse effects of SCI as people age there is a need to examine wheelchair transfer 
safety, UE joint injury prevention and preservation of function.  
Investigators have conducted comprehensive evaluations of UE kinematics,7,9-14 
kinetics15,16 and muscle activity as determined by EMG3,16 among individuals with SCI 
during numerous ADLs. However, few studies were identified, that specifically address 
transfers from a wheelchair to vehicle while capturing these three data types.17-19 
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1.2 Objectives of the Study 
This study evaluated at a series of independent unassisted and device-assisted 
transfers from a wheelchair to vehicle mock-up and vice versa while simultaneously 
capturing kinematic, kinetic and EMG data, facilitating observation and evaluation of UE 
joint stresses, muscular force and functional demands associated with transfers in 
persons with SCI to ultimately prevent UE injury, preserve functionality and limit pain. 
One general objective of this research was to explore whether any assistive devices are 
in fact beneficial to people with SCI. 
 
1.3 Significance of Work 
This study was performed following a pilot study that analyzed SCI patients 
transferring from a wheelchair to and from a hospital bed, commode mock-up and 
vehicle mock-up. It was found that transfers from wheelchair to vehicle and vice versa 
were distinctly the most difficult with respect to the stresses generated at the UEs. The 
study also found that capturing wheelchair to vehicle transfers is quite difficult, which is 
likely one reason there are few studies that have taken on the challenge. 
This previous study was conducted as part of the larger research efforts of the 
Tampa Patient Safety Center. The current study continues the research previously 
conducted and expands upon it by solely evaluating wheelchair to vehicle transfers and 
updating data acquisition methods. The pilot study conducted made use of a vehicle 
mock-up, which was an assembly of 2x4’s. The large cross-section was found to 
severely occlude markers. The new vehicle design adopted a more streamlined 
appearance, utilizing 2.54cm (1in) steel tubing, painted in a matte black to minimize 
reflections. Biomechanical models utilizing inverse dynamics from the previous study 
were also utilized for this current study to determine reaction forces at the UEs. The 
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current study will additionally look at the demands of stowing and retrieving a 
wheelchair, a necessary task if full independence is desired. 
This research adds to the understanding and knowledge that aims to improve 
how those with SCI can remain independent and mobile. Without the functional use of 
their UEs they must rely on others for the simplest of everyday tasks. It is important to 
discover and learn how SCI patients can continue to function independently.  With the 
technology available today and technology to be developed in the future, SCI patients 
will have the ability to live longer, healthier lives. 
The study was approved by the University of South Florida Institutional Review 
Board (IRB) and the James A. Haley Research and Development Committee. 
 
1.4 General Limitations 
During the process of conducting this study a number of limitations may have 
hindered the acquisition of the best possible data.   
For one, mock-up devices were utilized for data collection. The vehicle used for 
this study was a model essentially comprised of a steel frame. The seat of the vehicle 
may not have been properly adjusted for both a car and a truck or van and therefore 
could have affected the transfer height for the Ryno Lift mock-up transfers. The Glide ‘n’ 
Go mock-up also created non-level transfers, but to a lesser degree than those during 
the use of the Ryno Lift mock-up. 
 Data acquisition also presented some difficulties. Major challenges include 
markers and electrodes falling off during data collection, marker occlusions and marker 
labeling. In some cases EMG voltages were higher during the transfer trials than during 
the MVC trials and therefore % MVC values exceed 100%. 
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Participant recruitment also proved to be a challenge. In the span of 
approximately 18 months, data from only 5 subjects meeting the inclusion/exclusion 
criteria was able to be later processed and analyzed. 
 
1.5 Anatomy and Physiology 
The focus of this study is the UEs, so for a complete understanding a brief 
background of the anatomy is provided. 
The shoulder joint is a ball-and-socket joint which is designed for a wide range of 
motion (ROM). Movements of the shoulder include adduction/abduction, 
protraction/retraction and internal/external rotation. While the shoulder joint has the 
ability to move in all three planes, it is not a stable joint as is endemic of the lower 
extremities. This lack of stability increases the risk of injury such as dislocation and 
rotator cuff tears.20 The rotator cuff is the soft tissue which encapsulates the articulation 
of the humerus and glenoid surface of the scapula. Impingement, sprains, strains, 
arthritis and fracture are other common injuries of the shoulder. 
 The elbow joint acts as a hinge providing movement in a single plane 
(flexion/extension). The decreased ROM allows the elbow to have greater stability than 
that of the shoulder, also protecting it from a high risk of injury.20 
 The wrist, a condyloid joint, also allows for a wide ROM. The condyloid joint is 
similar to a ball-and-socket, but with an elliptical pathway. Movements of the wrist 
include flexion/extension, circumduction and pronation/supination. The latter occurs 
specifically at the distal radioulnar joint, which is a pivot joint formed by the articulation of 
the distal radius and ulna.20 
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Chapter 2 – Literature Review 
Across the globe there is an incidence of 15 to 40 cases per million of spinal cord 
injuries per year.  Approximately 12,000 cases of paraplegia and quadriplegia occur 
each year in the United States alone, with almost 60 percent surviving their injuries.2  
People with SCI rely on their UEs to perform everyday activities, such as 
wheelchair propulsion and transfers. Their ability to lead independent lives is directly 
influenced by the integrity of their UEs.21 Unlike the joints of the lower extremities, which 
are comprised of stable structures designed for load bearing and locomotion, the joints 
of the UEs are characterized by unstable structures specialized for ROM, but limited 
mechanical stress.7 Consequently, functions performed by the UEs that are typically 
performed by the lower extremities, may lead to musculoskeletal degeneration.3,7 
Multiple factors may contribute to UE joint degeneration and/or loss of function 
following SCI. These factors include age and length of time from SCI onset,9,22-25 
pain,3,12,22,26-29 UE joint and muscle strength deficiencies or imbalances,22,26,28,30-32 
exercise capacity and tolerance for the physical strain of ADLs,33-36 body mass and 
composition,14,16,37 previous UE injury or disease history,23 wheelchair-to-user 
interface,38-40 and transfer techniques.6,39,41,42 
 
2.1 Incidence of Pain  
Studies of manual wheelchair users indicate that UE pain is most common in the 
shoulders, wrists, hands and elbows.9,21,23,29,43,44 Within the SCI population, a reported 
1/3 to 1/2 suffer from UE pain and deterioration caused by the stresses of overuse.6-
9,12,23-26
 Respondents to a questionnaire administered by Gironda et al,44 reported 58.5% 
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had UE pain; 71% reported shoulder pain, 53% wrist pain, 43% hand pain and 35% 
elbow pain. Their study also reports veterans with paraplegia suffer from at least a 
minimal level of ongoing unspecified pain (81%) and/or current UE pain (69%).44 
Subbarao et al9 also indicated high instances of wrist and shoulder pain, with nearly 73% 
of respondents reporting some degree of chronic pain in one or both of these areas. The 
investigators concluded that alternative methods for transfers need to be developed for 
persons with SCI to lessen stress and cumulative trauma and thereby diminish the 
incidence of chronic UE pain.9 
Several epidemiological studies have been conducted for the purpose of 
investigating the prevalence and intensity of UE pain and its association with functional 
activities in individuals with SCI.3,6,21,29,43-45 Studies have found that incidence of UE pain 
is greatly increased during performance of ADLs. According to Dalyan et al,3 pain 
frequency and intensity of functional activities performed by SCI patients, it was found 
that pain interfered most during pressure reliefs, ambulation, transfers, upper body 
dressing and wheelchair mobility, indicating that UE pain may have a significant impact 
on functional independence.10 
A study by Gellman et al23 concluded that pain increased with time from the 
onset of SCI. This is supported by Lal’s7 finding that shoulder dysfunction appears to 
increase with time since onset of injury as well as age. Lal also reported a correlation 
between age and a higher level of wheelchair activity. While age has been found to be a 
common factor in shoulder pain,7,23,43,44 Pentland and Twomey21 concluded that shoulder 
pain was related to duration of wheelchair use, exclusive of age. Surprisingly, in a study 
by Fullerton et al,45 that compared athletes to non-athletes, it was found that there was 
no difference in duration of wheelchair use between the two groups. Gironda et al,44 
found that the duration of wheelchair use only modestly predicted shoulder pain 
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prevalence and intensity, while Wylie et al46 found that moderate joint activity protects 
the shoulders against degeneration. 
To measure the effect of rehabilitation on UE pain, strength and function, 
investigators have measured changes in physical capacity and performance during 
ADLs following rehabilitation.33,47 Van Drongelen et al47 evaluated persons with SCI and 
found that tetraplegics have more pain than paraplegics, UE pain was inversely related 
to function, and strength was inversely related to shoulder pain. Dallmejjer et al33 found 
that after rehabilitation it is important to continue activities to maintain and even improve 
physical performance. In general, better strength and function were related to reduced 
UE pain. This is supported by previous findings that protection of the joints is directly 
related to the strength of the surrounding muscles.21 
In an effort to determine the effects of UE pain, studies investigating the 
prevalence and intensity of pain during ADLs have reported high incidences of wrist and 
shoulder pain, which effectively leads to a loss of mobility and therefore independence. It 
is important to continue performing daily tasks to maintain or improve physical 
performance and to discover the biomechanically effective methods of these tasks to 
help prevent degeneration and UE pain. 
 
2.2 Biomechanics Studies 
Those with SCI are at considerable risk for injury to their UE, which is why 
studying how they perform various activities of daily living is critical for understanding 
and preventing injury so that patients can maintain their independence. Biomechanical 
models have been used to measure and predict UE kinematics and kinetics,48-51 
glenohumeral joint contact forces52,53 or pressure,6 and upper extremity muscle 
forces52,53  or activations48-50 with varying complexity and methodology. 
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Numerous studies evaluating the biomechanics of ADLs performed by SCI 
subjects address the effects on key muscle groups surrounding the glenohumeral 
joint.18,48-50,54-64 Typically, investigators used surface EMG to obtain muscle activation 
measurements. The main objective for those with SCI is to develop and maintain the 
ability to independently transfer and maneuver when performing ADLs.65 
 
2.2.1 Glenohumeral Contact Forces 
The glenohumeral joint is the most mobile articulation of the body, supported by 
the surrounding muscles to provide dynamic balance and stability.66 The calculation of 
glenohumeral contact forces has been modeled in various studies involving persons with 
paraplegia, tetraplegia and able-bodied persons for comparison.6,51-53 These studies 
provide insight into the effects of lesion level, ADL performance, BMI and anthropometric 
measurements on forces and moments produced at the joints of the UEs. 
Transfers are among the most demanding ADLs likely due to the asymmetry of 
tasks and the awkward postures required.53 Gagnon et al55 assessed sitting pivot 
transfers (SPTs) to compute joint forces and moments acting at the shoulders and 
elbows. For analysis, the transfer was divided into 3 phases: pre-lift, lift-pivot and post-
lift. Resultant joint forces show that more weight is being supported by the trailing UE at 
the beginning of the transfer in the pre-lift phase. The weight progressively shifts to the 
leading UE producing increasing resultant forces at the elbow and shoulder during the 
lift-pivot phase. The investigators found that peak resultant forces occurred at the trailing 
UE during transfers to a raised seat.55 
During a transfer, the weight of the body is transferred from the trunk through the 
clavicle and scapula across the glenohumeral joint to the humerus.6 Bayley et al6 used 
an arthrographically-placed catheter at the subacromial area of the shoulder joint to 
continuously measure arterial pressure during six different ADLs. They reported that 
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persons with paraplegia having a lower lesion level may be able to partially support their 
body weight during transfers using functional abdominal or spinal muscles, which may 
be vital to relieving excessive transfer forces imposed on the shoulders.6 The pressure in 
the shoulder joints during transfers usually exceeds mean arterial pressure by more than 
250%. The belief is that this high pressure in conjunction with abnormal stress across 
the subacromial area during a transfer contributes to the high rate of shoulder injuries in 
persons with SCI. 
 
2.2.2 Transfers 
Persons with SCI typically perform numerous transfers, potentially averaging 19 
transfers each day60 and as many as 35 daily.67 Since transfers require a high muscular 
demand it is necessary to understand task mechanics to minimize any adverse effects. 
The SPT method is defined by two seating surfaces angled anywhere from 2568 
to 65 degrees69 from each other, depending on patient preference, and is commonly 
performed unassisted by SCI persons with strong UEs. This setup requires a patient to 
place the leading arm on the target seat, or other support surface, with the trailing arm 
on the initial seat. Next they must lift their body weight by extending the elbows, 
depressing the shoulders, lifting the buttocks70 off the initial seat, then rotating their body 
in order to move to the target seat. This maneuver generates high mechanical loading at 
the UE.69 
The position of the UE during transferring is crucial to preventing injury. Koontz et 
al71 noted that when the arm is internally rotated and abducted it is in a position of 
impingement, but the severity of this can be avoided with the use of an assistive device. 
Perry et al50 found that the lift phase of a SPT required the greatest muscular 
effort by the lead arm. Gagnon et al55 evaluated SPTs at three different target seat 
heights; high, low and level. At the raised seat height it was found that the trailing UE 
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was affected by having to progressively increase elbow extension and angular velocity, 
while the leading UE reached peak extension angular displacement and velocity.64 
A number of studies have done further research into whether the leading or 
trailing arm is required to exert greater muscular exertion during transferring.67,72,73 In a 
study conducted by Cooper et al73 it was found that the trailing arm, in comparison, 
supported a higher percent body weight than the leading arm. Gagnon et al67 found only 
limited support that muscular demand is higher for the trailing UE. Upon further study 
they also found that muscular demand is similar in the preferred and non-preferred 
direction. 
In a similar study Finley et al56 compared scapular kinematics and muscle 
function of manual wheelchair users with and without shoulder impingement. They found 
that those with impingement performed transfers with significantly less thoracic flexion, 
increased scapular upward rotation, and reduced humeral internal rotation as compared 
to those without the pathology. 
Wang et al54 explored how reaction force and muscle activity change when 
transferring from a wheelchair to three different heights. Their study found that transfers 
to a higher surface resulted in a shift of the “friction force” from primarily anterior-
posterior to more medial-lateral and required a greater muscular contribution from the 
biceps brachii muscle. Ideally, seat height should be level with the individual’s 
wheelchair when performing a SPT due to less muscular effort required than transferring 
to an elevated or lowered target seat. Perry et al50 concluded that assessment of SPT 
skill should not be based on the ability to lift body weight alone, due to of the need for 
stabilization and lateral movements. 
These studies demonstrate the exceptional demands placed upon the UEs of 
persons with SCI, but little attention has been given to the evaluation of techniques71 and 
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assistive devices to reduce these demands and thereby reduce pain and extend 
function.  
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Chapter 3 – Methods and Procedures 
3.1 Screening and Selection Criteria  
5 males with paraplegia who use a manual wheelchair for mobility were recruited 
from the James A. Haley VA Hospital in Tampa, as well as the surrounding community. 
Respondents were pre-screened in person or by telephone. Qualifying participants were 
also screened in the lab, prior to informed consent, to assure they met 
inclusion/exclusion criteria. 
 
3.1.1 Inclusion Criteria 
1. Level of SCI will be limited to ASIA A classification at T2 through L5 level to 
standardize physical capabilities;  
2. SCI for at least 2 years (neurologically stable);  
3. Use a rigid manual wheelchair as a means of primary transportation;  
4. Able to self-propel wheelchair;  
5. Able to independently transfer between wheelchair and vehicle;  
6. Between the ages of 18-65;  
7. Able to follow simple instructions;  
8. Free from acute upper extremity injury for at least six months (determined by 
history review) to minimize risk of injury during task performance;  
9. Comparable bilateral functional range of motion and strength of the shoulders, 
elbows and wrists (determined by physical evaluation) to minimize risk of injury 
during task performance. 
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3.1.2 Exclusion Criteria  
Candidates who present: 
1. Extended bed-rest within the past 30 days;  
2. Ventilator-dependent;  
3. Any cardiac or respiratory condition that would limit subject’s physical 
performance;  
4. Unstable medical conditions;  
5. Clinical evidence of severe musculoskeletal disorders of the upper extremity 
were precluded from participating in this study. 
3.1.3 Participants 
An initial questionnaire to obtain demographic and anthropomorphic data was 
administered. Previous injuries and experience of pain were recorded, as were daily 
activities performed recreationally and professionally. Table 3.1 shows anthropometry 
and demographics of the 5 participating subjects. Most subjects also participated in 
recreational activities including swimming, weight training, horseback riding, golf and 
rugby.  
A board-certified physician, who practices Spinal Cord Injury Medicine, 
performed a physical evaluation of each candidate to verify upper extremity and spine 
integrity in order to determine their eligibility for the study. This evaluation included a 
review of the candidate’s historical file, a functional strength test and ROM. 
Some possible anomalies amongst the study participants were noted, including: 
Subject 1 was the only subject with an incomplete injury; he has some motor function 
and is receiving ambulatory training, but lacks sensory function. Subject 2 was the only 
subject who did not report performing any physical activities. Subject 4 was the victim of 
a traumatic brain injury (TBI), which occurred in conjunction with his spinal cord injury. 
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Table 3.1: Subject Anthropometry and Demographics. 
 
 
 
Subject Mean St. Dev Range 
 
1 2 3 4 5 
   
Age (years) 51 61 59 53 38 52 9.0 38 - 61 
Weight (kg) 63.5 127 90.7 68.0 99.8 89.8 25.7 63.5 - 127 
Stature (m) 1.70 1.85 1.73 1.65 1.83 1.75 0.09 1.65 - 1.85 
BMI (kg/m2) 22.0 37.1 30.3 25.0 30.0 28.9 5.75 22.0 - 37.1 
Gender M M M M M 
 
Injury Duration (years) 7.3 3.3 26.8 2.1 6.1 9.1 10.1 2.1 - 26.8 
Level of Injury T4 T10 T6 T11 T8 
 
Completeness Incomplete Complete Complete Complete Complete 
 
Ethnicity Hispanic Caucasian Caucasian Caucasian Caucasian 
 
Dominant Hand Right Right Right Right Right 
 
Regular Exercise Yes No Yes Yes Yes 
 
Smoker No No No No No 
 
Other 
   
TBI 
  
3.2 Data Acquisition and
Kinematic data was collected using a Vicon Motion Analysis system
system has 13 MX40 cameras, which emit infrared light, to capture a full
set of 63 spherical 9mm diameter reflective markers
3D real-time information; the smallest 
calibrated statically and dynamically prior to data collection 
static calibration frame and dynamic wand each with integrated reflective markers
(Figure 3.2). Data was captured at 30 frames per second. 
including force transducer
Vicon’s MX Control, MX Link and MX Net
Data was initially 
to label all markers. The auto
configuration that was utilized for this study. Due to marker occlusions and in some 
cases mis-labeling, all kinematic trials were viewed frame by frame to manually label and 
re-label markers. 
 
Figure 3.1: Motion Capture 
top right clockwise) individual markers, as well as gloves, triads, and a headband
each with integrated markers. B
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 Processing 
 (Figure 3.1). This system captures 
measurable movement is 0.1 mm. The system is 
using a specifically 
All peripheral 
s, EMG and a digital video camera, are interfaced
 to allow all data to be captured simultaneously
processed using Vicon Nexus. An auto-label function was used 
-label function is defined by a template of the marker 
 
      A.                   B
Components. A. Reflective markers including (from 
. Vicon MX40 infrared camera. 
.
74
 This lab’s 
-body marker 
designed 
 
components, 
 using 
.  
 
. 
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A. 
 
B. 
Figure 3.2: Calibration Devices. A. Static calibration frame. Defines the origin 
of the motion capture area. B. Dynamic calibration wand.  
 
The vehicle mock-up (Figures 3.3 and 3.4) is composed of a frame of 2.54cm 
(1in) steel tubing painted a matte black to minimize marker occlusion and excessive 
reflection, respectively. The base of the vehicle is wood, supported by a steel grid. 
Wheels were attached for ease of movement and height. The vehicle mock-up was 
designed with 7 integrated AMTI75 6 degrees-of-freedom (DOF) force transducers, 4 in 
each corner of the base of the vehicle as well as one in the steering wheel, grab handle 
and vehicle door (Figure 3.5). The analog signal via the force transducers was amplified 
and conditioned before being converted to a digital signal. In Vicon Nexus, force 
transducers were imported as AMTI OR6 force plates. Calibration matrices, location and 
orientation of force transducers were defined in the software. Only data for the force 
transducers located at the wheel, handle and door were processed. Data will only be 
analyzed when a single segment (e.g. hand) is applying a load to the transducer. Forces 
were verified using a Chatillon manual force gage.76 
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Figure 3.3: Vehicle Model without Platform. This represents a truck or other 
raised chasse vehicle. The floor of the vehicle measures 60cm from the ground. 
The base of the car measures 168cm width by 186cm depth. This truck model 
was used for transfers utilizing the Easy Reach and Glide ‘n’ Go mock-up. 
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Figure 3.4: Vehicle Model with Platform. This represents a vehicle mock-up 
with platform to represent a car. The vertical distance from the platform to the 
vehicle measures 25cm. The platform was designed with a ramp for easy 
wheelchair access with a slope of ~8 degrees. This model was utilized for the 
unassisted transfer and when using the transfer board. 
 
EMG data was collected using a Delsys Bagnoli Desktop System77 utilizing 10 
channels to collect bilateral data of 5 muscles (Table 3.2). Each electrode has 2 1mm by 
1cm Silver (99.9% Ag) bar sensors spaced 1cm apart (Figure 3.6).78 Placement of each 
electrode is detailed in Table 3.2. After the area was cleaned with alcohol Delsys 
electrodes were placed perpendicular to muscle fibers with a reference sensor placed on 
the bony prominence at C7. Maximum voluntary contraction (MVC) data was collected 
as well as muscle activity during each trial.  
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A. 
 
              B. 
 
                       C. 
Figure 3.5: Integrated Force Transducers. A. Steering wheel. B. Grab handle. 
C. Vehicle door support. 
 
 
Figure 3.6: EMG Electrodes. Surface EMG sensor and reference sensor. 
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Table 3.2: EMG Electrode Location.79 
Muscle Location of EMG electrode 
Anterior Deltoid in neutral position, measure 3 fingerbreadths below the bony prominence of the acromion, anteriorly 
Latissimus Dorsi in neutral position, measure 3 fingerbreadths below the posterior axillary fold 
Pectoralis Major in neutral position, anterior position just below the axillary fold 
Upper Trapezious angle of neck and shoulder 
Long Head Triceps with arm abducted 90°, measure 4 fingerbreadths distal  from the posterior axillary fold 
 
Subjects were measured for their MVC using the equipment shown in Figure 3.7. 
After EMG electrodes were applied bilaterally to the anterior deltoids, latissimus dorsi, 
pectoralis major, upper trapezius and long head of triceps, participants were asked to 
perform weight lifting exercises in best attempt to isolate each of these muscles. A single 
exercise was chosen for each muscle group. An arm raise for the anterior deltoids, a lat 
pull-down for the latissimus dorsi, a pec fly for the pectoralis major, a shoulder shrug for 
the upper trapezius and a push-bar with tucked arms for the triceps.  The data collected 
during each exercise provided a maximum voltage output or maximum muscle exertion 
for each muscle measured, which will be used in comparison to the EMG readings 
captured during the wheelchair transfer trials. EMG readings will be presented as a 
percentage of the MVC measurements.  
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Figure 3.7: MVC Equipment. Equipment used in measuring maximum muscle 
activity at each muscle group. This equipment has numerous fixture settings for 
appropriate positioning for each exercise to stimulate each of the 5 muscle 
groups. The volunteer shown is performing an exercise to measure the MVC of 
the pectoralis major. 
 
After MVC data was collected, 63 reflective markers were placed on the subject 
for collection of kinematic data. Figure 3.8 shows full-body marker placement. The Vicon 
motion capture system was then calibrated and force transducers zeroed prior to data 
collection.  
Before wheelchair transfer trials a static kinematic trial of ~3 seconds was 
captured. This data was then used to calibrate the subject to a marker template that was 
previously created. This template created in Vicon Nexus defines each marker, the 
relative location of all markers to one another and defines bodily segments, which are 
characterized by a minimum of 3 markers. 
Figure 3.8: Marker Placement Protocol. 
capture full body kinematics. 
minimize marker occlus
 
Subjects were asked to perform transfers from their wheelchair to and from a 
vehicle mock-up, which was versatile in that it c
Vehicle Model without Platform
Vehicle Model with Platform
were asked to only perform at their ability to prevent injury. In the event of a fall, a ceiling 
lift was in place that could traverse the entire lab. The transfer tasks included the use 
4 different commercially available devices, or mock
unassisted independent transfer. These devices were chosen to explore user 
independence as well as offer a full range of transfer difficulty. Participants were also 
asked to stow and remove
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63 reflective markers were used to 
Triads are composed of 3 raised markers to 
ion and easily define segments.19 
ould represent a truck (Figure 3.3
) or a car with the addition of a platform (Figure 3.4
). Five tasks were designated for data capture, but subjects 
-up of the device, as well as an 
 a standard wheelchair (Figure 3.9) once at each height. This 
 
: 
: 
of 
 Triad   
   Marker 
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rigid frame Quickie GT81 has an aluminum frame, 40.6cm x 40.6cm (16in x 16in) seat, 
61cm (24in) wheels and a weight of 91.2 N (20.5 lbs.). The seat back was set at a height 
of 28cm (11in), measured from the height of the uncompressed 5cm (2in) removable 
cushion. The wheelchair was stripped of armrests and anti-tip assembly. Data collection 
took approximately four hours per subject. 
 
 
Figure 3.9: Standardized Wheelchair. Used for trials requiring the stowage and 
removal of a wheelchair. 
 
Between tasks, subjects were asked to rate their level of pain and how safe they 
felt during the task (Table 4.6: Pain Questionnaire and Table 4.7: Transfer Device 
Questionnaire). A period of rest and recovery was also permitted between tasks. The 
order of task performance was randomized between and within car and truck model as 
shown in Table 3.4. 
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Table 3.3: Task Randomization Table.  
Subject Task 
 
1 2 3 4 5 
1 Transfer Board Unassisted Glide 'n' Go Easy Reach Ryno Lift 
2 Ryno Lift Easy Reach Glide 'n' Go Transfer Board Unassisted 
3 Easy Reach Glide 'n' Go Ryno Lift Unassisted Transfer Board 
4 Unassisted Transfer Board Ryno Lift Easy Reach Glide 'n' Go 
5 Unassisted Transfer Board Glide 'n' Go Ryno Lift Easy Reach 
 
 
3.3 Wheelchair Transfers 
Transfer studies among SCI subjects should consider factors including age, 
overall medical status, length of time since disability, wheelchair transfer strategies, 
muscular strength, physical strain of daily activities, body mass and composition, and UE 
injury history. This SCI subject transfer study utilized kinematic, kinetic and EMG data. 
Combined, these data sets allow for a complete look at the demands placed on the UE, 
particularly at the shoulder joint, during wheelchair transfers. 
The following five transfer methods from wheelchair to vehicle are described in 
detail. They include Glide ‘n’ Go mock-up, Ryno Lift mock-up, Easy Reach, transfer 
board and an unassisted independent transfer, which used no device for assistance. 
Subjects performed transfers from their personal wheelchair. 
Prior to data collection subjects were given a thorough explanation of the transfer 
tasks including the use of each device. Subjects were also shown a video of a 
researcher performing each task. This was done as a safety precaution and not with 
cause to influence the subject. All transfers were performed at the subjects own pace. 
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3.3.1 Glide ‘n’ Go Mock-up 
The Glide ‘n’ Go (Figure 3.10 – 3.12) was designed for persons who are semi-
ambulatory to able-bodied.82 It may also be acceptable for use by high functioning 
paraplegics. A mock-up model was used for testing, as the actual device was not 
acquired. The seat measured 41cm with a 39cm depth. The commercial device is 
designed to fold away into the vehicle for easy storage. This device required the subject 
to perform 4 separate transfers: wheelchair to Glide ‘n’ Go, Glide ‘n’ Go to vehicle seat, 
vehicle seat to Glide ‘n’ Go, and Glide ‘n’ Go back to wheelchair.  Transfers between the 
Glide ‘n’ Go and vehicle seat were level transfers, while the transfer from the wheelchair 
to the Glide ‘n’ Go mock-up was a raised transfer. On the return, the wheelchair was 
lower than the Glide ‘n’ Go seat. The manufactured device would ideally allow each 
transfer to be level. 
 
 
A. 
 
B. 
Figure 3.10: Glide ‘n’ Go Mock-up. The Glide ‘n’ Go mock-up was designed 
with a ceiling lift for subject controlled vertical height. Image A. shows device in 
lowest position and B. shows the higher transfer position. 
A. 
Figure 3.11: Glide ‘n’ Go Transfer In.
Glide ‘n’ Go. A. Captured video from the tria
Nexus. 
 
A. 
Figure 3.12: Glide ‘n’ Go Transfer Out.
Glide ‘n’ Go to vehicle seat.
from Vicon Nexus. 
 
 
3.3.2 Ryno Lift Mock-up
The Ryno Lift83 (F
as an under-chassis lift that can be used with a van, truck or sports utility vehicle. A 
hydraulic scissor lift table
original device. Once the subject was on the lift they locked their wheels and were
lifted by researchers to the height of the vehicle floor. Data collection started once the 
subject was in the passenger area of the vehicle. As th
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B. 
 Subject transferring from wheelchair to 
l. B. Screen capture
 
B. 
 Snapshot of subject transfer
 A. Captured video from the trial. B. Screen capture 
 
igure 3.13 – 3.14) is a commercially available de
84
 with a capacity of 4,448N (1,000lbs) was used to model the 
e subject transferred to the 
 
 from Vicon 
 
ring from 
vice designed 
 then 
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vehicle seat from their wheelchair they performed a downward transfer and a raised 
transfer as they transferred back to their wheelchair. Ideally, when installed in a patient’s 
vehicle a level transfer could be performed. 
 
 
Figure 3.13: Ryno Lift Mock-up.  Image of device in the raised position, level 
with the base of the vehicle. 
 
 
A. 
 
B. 
Figure 3.14: Ryno Lift Transfer In. Snapshot of subject transferring from their 
wheelchair to vehicle seat. A. Captured video from the trial. B. Screen capture 
from Vicon Nexus. 
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3.3.3 Easy Reach 
The Easy Reach82 (Figure 3.15 – 3.16) was designed for those with disability 
range between quadriplegic and semi-ambulatory. This device allows the vehicle 
manufacturer’s seat to be modified to swivel out of the vehicle without compromising the 
safety of the seat itself. This device has a user-operated switch, which adjusts the seat 
to the desired vertical height; therefore a level transfer can always be performed. 
 
 
Figure 3.15: Easy Reach. Image of Easy Reach in the lowered position. 
 
 
A. 
 
B. 
Figure 3.16: Easy Reach Transfer Out. Snapshot of subject transferring from 
Easy Reach to their wheelchair. A. Captured video from the trial. B. Screen 
capture from Vicon Nexus. 
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3.3.4 Transfer Board 
The transfer board (Figure 3.17 – 3.18) is a device commonly introduced during 
rehabilitation to aid in transferring. It is used for a wide range of transfers and allows a 
person with SCI to use the device as a bridge to maneuver from one seat to another. 
The transfer board is also very portable for easy use in any environment. The transfer 
board used for the study measured 71cm by 21cm. 
 
 
Figure 3.17: Transfer Board. Image of transfer board between wheelchair and 
vehicle seat. 
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A.  B. 
Figure 3.18: Transfer Board Transfer In. Snapshot of subject transferring from 
wheelchair to vehicle with use of transfer board. A. Captured video from the trial. 
B. Screen capture from Vicon Nexus. 
 
 
3.3.5 Unassisted 
An unassisted transfer was also performed (Figure 3.19). This transfer did not 
permit the use of any assistive devices. The transfers were performed with the platform 
in place and therefore allowed the transfers into and out of the vehicle to each be level 
transfers. 
 
 
A. 
 
B. 
Figure 3.19: Unassisted Transfer In. Snapshot of subject transferring from their 
wheelchair to the vehicle seat with no assistive device. A. Captured video from 
the trial. B. Screen capture from Vicon Nexus. 
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3.4 Data Analysis 
After data processing, which included manually labeling markers, and replacing 
missing and occluded markers via BodyBuilder74 using a custom BodyLanguage74 code, 
data was also analyzed using BodyBuilder. Analysis outputs provided include 
anthropometry of all body segments, joint centers of the shoulder, elbows and wrists, as 
well as tri-axial kinematics and kinetics of the joints. After data was run through 
BodyBuilder, a custom MATLAB85 code was utilized for data reduction. Microsoft Excel 
was used for further data reduction and graphic analysis. 
 
3.4.1 Kinetics 
After kinetic data was exported from BodyBuilder, MATLAB was utilized for data 
reduction. A custom code was utilized to calculate fast Fourier transforms (FFTs) to 
determine the frequency range of the data (Figure 3.20). Based on the FFT plot this data 
was then filtered using a recursive 4th order Butterworth low-pass filter with a cutoff 
frequency of 5Hz. The root mean square (RMS) max and mean values of each joint’s X, 
Y and Z components were calculated. Resultant max and mean forces and moments 
were then saved as comma separated variable (CSV) files to be further manipulated in 
Excel. Kinetic data was grouped by task and transducer location and then averaged 
across subjects. 
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Figure 3.20: FFT of Force Data. Shows frequency range of force data to 
determine which filter and filter parameters to apply. 
 
 
After the filter was applied to the kinetic data a plot (Figure 3.21) of the effect of 
the filter was generated to validate the use the filter parameters. 
 
 
Figure 3.21: Force Filter Effect. After kinetic data was filtered, the original and 
filtered data were graphed to assure proper filtering. 
 
 
External forces at the joints of the UE were calculated using inverse dynamics, 
specifically at the wrists, elbows and shoulders. Scalars and vectors to consider include 
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the mass and weight of body segments, center of mass (COM), anthropometry of body 
segments and external forces and moments generated by the hands. A free body 
diagram shows a general description of the forces acting on the UE (Figure 3.22).  
 
 
Figure 3.22: Free Body Diagram. 
 
 
3.4.2 Kinematics 
After kinematic data was exported from BodyBuilder, MATLAB was utilized for 
data reduction. A custom code was utilized to calculate FFTs. This data was then filtered 
using a recursive 4th order Butterworth low-pass filter with a cutoff frequency of 5Hz. 
Mean values were then saved into their positive and negative X, Y and Z components to 
CSV files. Figure 3.23 and Table 3.4 show the tri-axial definitions used for the UEs. 
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Table 3.4: Definition of Upper Extremity Joint Rotation References. 
Joint 
Axis of 
Rotation Definition 
Shoulder Representative of a ball-and-socket joint 
 
X Adduction/Abduction 
Movement of the arm at the shoulder, towards or away from the body, 
respectively, with respect to the sagittal plane 
Y Protraction/Retraction 
Movement of the arm, at the shoulder, anterior or posterior, respectively, with 
respect to the coronal plane 
Z Internal/External Rotation 
Movement of the arm, at the shoulder, rotated medial or laterally, respectively, 
to the midline 
Elbow Representative of a hinge joint 
 
Y Flexion/Extension 
Flexion is a bending at the joint that decreases the angle between two bodies. 
Extension increases this angle 
Wrist Representative of a condylar joint 
 
Y Flexion/Extension 
Flexion is a bending at the joint that decreases the space between the palm 
and the forearm. Extension increases this angle 
Z Pronation/Supination 
Movement of the palm from anterior to posterior and reverse, respectively 
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Figure 3.23: Upper Extremity Joint Definitions. Defines X, Y and Z of each 
joint of the upper extremities. 
 
 
Figure 3.24 shows an issue that arose with the kinematic data. While graphically 
it appeared that there was a distinct change in the angle about the X-axis 
(abduction/adduction) the motion capture data (left) shows essentially no change in the 
movement of the left arm. At this time the problem, which is thought to be software 
related, has yet to be resolved. Consequently, this will be the extent of the kinematic 
data presented. 
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Figure 3.24: Kinematic Error. The left shows an angular shift of approximately 
180 degrees, while the right shows no visible changes to the left shoulder joint. 
 
 
3.4.3 EMG 
EMG data was first exported directly from Vicon Nexus. A custom MATLAB code 
was utilized to calculate FFTs to determine the frequency range of the data (Figure 
3.25). EMG data was sampled at 960Hz. This data was then filtered using a recursive 4th 
order Butterworth band-pass filter with cutoff frequencies of 50 and 479Hz. Next a 
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moving average, with an epoch of 40 milliseconds, was applied with full wave rectified 
data to create a linear envelope.86 Epoch was determined based on the speed of bodily 
motion within the trial. A longer epoch is used for a slower trial.86 The max value of each 
muscle group per trial was then saved to a CSV file. Microsoft Excel was then used for 
further data reduction.  
 
 
Figure 3.25: FFT of EMG Data. Shows frequency range of EMG data to 
determine which filter and filter parameters to apply. 
 
The artifact at ~60Hz can be attributed to power line noise being picked up by the 
EMG equipment. Filter effect plots were also generated. Figure 3.26 shows an EMG 
signal from the MVC trials in which the subject was trying to exert his maximum muscle 
exertion. Approximately 3 seconds of effort is seen before the subject relaxed as asked 
via the data collection protocol. The following, Figure 3.27, shows the filter effect for 
EMG captured during a wheelchair transfer trial. 
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Figure 3.26: MVC Calibration Filter Effect. After MVC data was filtered, the 
original and filtered data were graphed to assure proper filtering. 
 
 
Figure 3.27: Wheelchair Transfer EMG Filter Effect. After EMG data was 
filtered, the original and filtered data were graphed to assure proper filtering. 
 
3.5 Data Reduction and Statistical Analysis 
A transfer is defined as the movement from the initial seat to the target seat (e.g. 
wheelchair to vehicle seat). Wheelchair transfer trials contained data prior to and post 
transfer; this was defined as a “full transfer trial”. Full transfer trials were further cropped 
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to define specific “events” that occurred during the transfer motion. This method was a 
product of the poor kinematic data and lessened the number of frames in which markers 
needed to be manually labeled. An “event” is a sequence during a transfer in which the 
left or right hand contacted a force transducer (steering wheel, grab handle or vehicle 
door) and generated a measurable force. The beginning and end of an “event” was 
based on visual inspection from motion capture data, a digital video camera and 
graphical force data. 
Force data was normalized by the subject’s body weight and moments were 
normalized by the subject’s body weight and stature.87-89 Kinetic data reports results 
based solely on “event” trials. These trials were then grouped by task or transducer 
location (vehicle door, grab handle and steering wheel). Forces and moments for each 
UE joint location were averaged across the 5 subjects. Standard deviations for these 
values come from the variability across subjects. 
Electromyographic % MVC data was grouped by subject, task, leading versus 
trailing arm, and vehicle height and further separated by trial type: wheelchair transfer or 
wheelchair stowage. With the transfer trials defined as full transfer trials and “event” 
trials. EMG data is all represented as % MVC (EMG/MVC*100). Data was average 
across subjects and muscle groups. % MVC data is presented as box plots with outliers 
defined as 1.5*IQR. 
Statistical differences were determined though analysis of variance (ANOVA) at a 
95% confidence interval. In some cases a 2-sided t-test with the assumption of unequal 
means was used to determine statistical significance. All statistically significant values 
are p≤0.05. 
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3.6 Equipment Uncertainty 
3.6.1 Force Transducers 
Table 3.5: MC3A Series AMTI Force/Torque Sensors Specifications.75 
Measurement Units Door/Handle Wheel 
Gain V/V 4000 1000 
Capacity  N (lb) 2200 (500) 4400 (1000) 
Fx, Fy Sensitivity  mV/(V*N) 
(mV/(V*lb)) 
0.67 (3.0) 1.35 (6.0) 
Fz Sensitivity  0.17 (0.75) 0.34 (1.5) 
Mx, My Sensitivity  mV/(V*Nm) 
(mV/(V*lb*in)) 
35.4 (4) 70.8 (8) 
Mz Sensitivity  26.5 (3.0) 53.1 (6.0) 
 
 
3.6.2 Signal Amplifiers 
Each AMTI amplifier has 6 channels each with an anti-aliasing low-pass filter with 
a 1000 Hz cutoff frequency. 
 
 Table 3.6: MSA-6 MiniAmp AMTI Amplifier Specifications.80 
Measurement Units  
Gain V/V 1000, 4000 
Excitation Voltage V 2.5, 5, 10 
Output Signal  V 10 
 
 
3.6.3 EMG System 
 Table 3.7: Delsys System Specifications.77,78 
Measurement Units Quantity 
Surface EMG Sensors 
Preamplifier Gain V/V 10 ±1% 
Noise µV 1.2 
Bagnoli Desktop EMG System  
Overall EMG Amplification  1000 ±1% 
EMG Bandwidth Hz 20-450 ±10% 
Noise  µV ≤1.2 
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Chapter 4 – Results 
4.1 Kinetics 
Two selections of data are presented to show dynamic force results from the 
wheelchair transfers. One from the right UE, during a transfer using the transfer board 
where the subject utilized the steering wheel to assist with their transfer (Figure 4.1) and 
the other from the left UE also during a transfer using the transfer board where the 
subject utilized the grab handle of the vehicle to assist with his transfer (Figure 4.2). 
 
 
Figure 4.1: Forces of the Right Upper Extremity. Plot of force applied by the 
right hand to the steering wheel during a transfer trial, which utilized the transfer 
board. 
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Figure 4.2: Forces of the Left Upper Extremity. Plot of force applied by the left 
hand to the grab handle during a transfer trial, which utilized the transfer board. 
 
 Subjects were asked to perform up to 10 transfers in approximately 4 hours. 
Table 4.1 shows a catalog of transfer trials and events that occurred during each trial. An 
“event” is a sequence during a transfer in which the left or right hand contacted a force 
transducer and generated a measurable force. The transfer is the time from when the 
subject left the initial seat and then moved to the target seat. The beginning and end of 
an event was based on visual inspection from motion capture data, a digital video 
camera and graphical force data. 
 
Table 4.1: Wheelchair Transfer Trial Catalog. 
Trials Subject 
1 Events 2 Events 3 Events 4 Events 5 Events 
Tr
a
n
sf
er
 
Bo
a
rd
 
A  1b  2b 2b  2b  
1b 1b 
2b  1b 2a 
B  1a n/a    1a 1a  1a  2a 
Un
a
ss
ist
e
d 
A   n/a    2b  2a 2b  2a 
B  2a  2a n/a    2a  2a 
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Table 4.1 (continued) 
G
lid
e
 
'n
' 
G
o 
A  1b 3b n/a   n/a       2a  
B  1a 3b n/a   n/a    2a  2a  
Ry
no
 
Li
ft 
A  1b  1a n/a    1a 2b  1b 
B  1b n/a   n/a    1b  1b 
Ea
sy
 R
e
a
ch
 
A   n/a        
B   n/a            
Table 4.1: Legend:  
• A: Transfer into vehicle from wheelchair; B: Transfer from vehicle back to 
wheelchair.  
• A check mark () denotes a “good” trial. Data could be processed and events 
could be defined. 
• An X () denotes that a trial was captured, but there were no events or the data 
could not be processed and therefore no events were defined. 
• n/a denotes that no trial exists. 
• 1: Event occurring on the steering wheel of the vehicle; 2: Event occurring on the 
grab handle of the vehicle; 3: Event occurring on the door of the vehicle.  
o a: Right hand; b: Left hand. 
 
 
Force and moment data presented does not capture the Easy Reach as per 
Table 4.1. Subjects were not in the vicinity of the steering wheel, grab handle or vehicle 
door during the transfer and therefore no kinetic data was captured for these trials. Data 
for other device assisted transfers (transfer board, Glide ‘n’ Go, and Ryno Lift) as well as 
the unassisted transfer are presented.  
Force has been normalized by body weight of each subject (Figures 4.3 and 
4.4).87-89 The highest forces, across all joints, were seen during the unassisted 
wheelchair transfers followed by transfers using the Ryno Lift mock-up at the left arm 
(Figure 4.3). The Glide ‘n’ Go mock-up had the lowest forces when averaged across all 
joints. Two statistically significant groups were found for the joints of the left UE. The 
Glide ‘n’ Go and transfer board trasnfers were different from the unassisted and Ryno 
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Lift transfers. The joints of the right UE showed significant differences between only the 
unassisted and Ryno Lift transfers. 
Mean data shows a similar trend to max data in that the unassisted wheelchair 
transfers generated the greatest forces across all joints while the Glide ‘n’ Go maintained 
the lowest average forces (Figure 4.4). Statistical significance was found only at the left 
UE. The Glide ‘n’ Go and transfer board transfers were found to be different from the 
unassisted and Ryno Lift transfers.  
 
 
Figure 4.3: Max Forces per Transfer Task, Normalized. 
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Figure 4.4: Mean Forces per Transfer Task, Normalized. 
 
Glide ‘n’ Go transfers were typically performed with the right arm generating 
force, except for on one occasion. Subject 1 was the only subject who generated any 
force with the left hand during a transfer. Therefore, forces of the left arm during the 
Glide ‘n’ Go task appear to have no variability, but actually the value is from a single trial 
and cannot be statistically tested. 
 Table 4.2 (mean (st. dev)) shows summarized absolute and normalized data 
averaged across all joints per each task. Further complimentary data that has not been 
normalized to body weight can be found in Appendix F. 
 
Table 4.2: Mean Forces Across UE Joints per Task.  
 Transfer 
Board Unassisted Glide ‘n’ Go Ryno Lift 
Max Force  
(N) 
299  
(6) 
478  
(15) 
262  
(92) 
317  
(128) 
Max Force Normalized 
(N/N*100) 
35.8  
(2.4) 
58.8  
(4.7) 
36.9  
(9.1) 
39.0  
(21.0) 
Mean Force  
(N) 
118 
(13) 
202 
(8) 
100 
(46) 
135  
(31) 
Mean Force Normalized 
(N/N*100) 
14.1 
(1.9) 
25.6  
(0.7) 
13.9  
(5.1) 
16.2  
(6.2) 
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 Figure 4.5 presents the max moments and Figure 4.6 mean moments that 
occurred at each joint per transfer task. Moments were normalized by body weight and 
stature to eliminate any bias based on these measures.87-89 Moment arms were 
calculated from the center of pressure (COP) where the hand applied force to the 
transducer 
There is a high degree of subject variability within this data especially at the 
shoulders and in the case of the max right wrist during the unassisted transfer. The high 
subject variability at the right wrist is due to subject 4 who generated a force at the grab 
handle that was ~10 times that of the other subjects (Figures 4.5 and 4.7). The highest 
moment was generated at the left shoulder during use of the Ryno Lift. 
Statistically significant groups were found at the left and right elbows in Figure 
4.5. At the left elbow the Ryno Lift and unassisted transfers were found to be different 
from the Glide ‘n’ Go and transfer board transfers. At the right elbow it was found that 
the Ryno Lift was different from the unassisted and Glide ‘n’ Go transfers. 
In Figure 4.6 statistically significant groups were found at the left elbow and left 
wrist, with no differences found at the right UE. At the left elbow and left wrist the Ryno 
Lift and unassisted transfers were found to be different from the Glide ‘n’ Go and transfer 
board transfers. At the left wrist the same two groups were found. 
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Figure 4.5: Max Moments per Transfer Task, Normalized. 
 
 
Figure 4.6: Mean Moments per Transfer Task, Normalized. 
 
Table 4.3 (mean (st. dev)) summarizes the moments of the absolute and 
normalized data averaged across all joints per each task. Further complimentary data 
that has not been normalized to body weight and stature can be found in Appendix F. 
0%
2%
4%
6%
8%
10%
12%
14%
16%
18%
20%
M
o
m
en
t/(
Bo
dy
 
W
ei
gh
t*
St
at
u
re
) (N
m
m
/(N
*
m
m
)
Max Moment Normalized
Transfer Board
Unassisted
Glide 'n' Go
Ryno Lift
Left Left Elbow            Left Wrist               RIght RIght Elbow         Right Wrist
Shoulder                                                                    SHoulder
0%
1%
2%
3%
4%
5%
6%
7%
M
o
m
en
t/(
Bo
dy
 
W
ei
gh
t*
St
at
u
re
) (N
m
m
/(N
*
m
m
)
Mean Moment Normalized
Transfer Board
Unassisted
Glide 'n' Go
Ryno Lift
Left Left Elbow            Left Wrist               RIght RIght Elbow         Right Wrist
Shoulder                                                                    SHoulder
48 
 Across all joints the Ryno Lift transfer generated the highest moments while the 
Glide ‘n’ Go generated the lowest. The unassisted transfer, however, generated 
moments nearly as high as the Ryno Lift mock-up. 
 
Table 4.3: Mean Moments Across UE Joints per Task. 
 Transfer 
Board Unassisted Glide ‘n’ Go Ryno Lift 
Max Moment  
(Nmm) 
64366 
(35429) 
76607 
(41563) 
46885 
(32874) 
76712 
(69971) 
Max Moment Normalized 
(Nmm/Nmm*100) 
4.6  
(2.5) 
5.4  
(2.8) 
3.9 
(2.6) 
5.5  
(5.5) 
Mean Moment  
(Nmm) 
21871 
(12995) 
27809 
(18852) 
16736 
(13320) 
31431 
(23855) 
Mean Moment Normalized 
(Nmm/Nmm*100) 
1.5  
(0.9) 
2.0  
(1.4) 
1.4  
(1.0) 
2.1  
(1.8) 
 
 Figures 4.7 and 4.8 show moments that occurred by transducer location without 
task consideration. When moments were averaged across all joints of the UE it was 
found that the highest moments occurred at the steering wheel, with the grab handle at a 
close second. Force was only applied to the door by the left hand, therefore moments 
are only presented for the left arm at the vehicle door. 
 Statistically significant differences were found at the left shoulder, right shoulder 
and right elbow (Figure 4.7). At the left shoulder the steering wheel was found to be 
different from the vehicle door and the grab handle. At the right shoulder and right elbow 
the steering wheel and grab handle were significantly different from each other. 
 In Figure 4.8 statistically significant differences were found at the left shoulder, 
right elbow and right wrist. At the left shoulder the steering wheel was different from the 
vehicle door and the grab handle. At both the right elbow and right wrist the steering 
wheel and grab handle were found to be significantly different.  
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Figure 4.7: Max Moments per Transducer Location, Normalized. 
 
 
Figure 4.8: Mean Moments per Transducer Location, Normalized. 
 
 The greatest variability was found at the steering wheel. The highest moment 
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the highest mean average (Table 4.4). The greatest variability continues to be seen at 
the shoulders and the right wrist. 
 
Table 4.4: Mean Moments Across UE Joints per Transducer Location. 
 Vehicle Door Grab Handle Steering Wheel 
Max Moment  
(Nmm) 
20304  
(18139) 
72316  
(43908) 
76167  
(58511) 
Max Moment Normalized 
(Nmm/Nmm*100) 
1.9  
(1.7) 
4.8  
(2.8) 
5.8  
(4.4) 
Mean Moment  
(Nmm) 
5649.9  
(3812) 
26282  
(18108) 
25569  
(20357) 
Mean Moment Normalized 
(Nmm/Nmm*100) 
0.5  
(0.4) 
1.8  
(1.2) 
1.9  
(1.5) 
 
 
4.2 Wheelchair Stowage 
 
 
Figure 4.9: Number of Hand Positions per Subject. 
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4.5 shows a summary of the data in Figure 4.9. Subject 4 was found to be significantly 
different from subject 1 and subject 5. 
 
Table 4.5: Number of Hand Positions per Subject. 
Subject Mean St. Dev. 
Subject 1 6 ±2 
Subject 2 6 ±2 
Subject 3 7 ±1 
Subject 4 12 ±3 
Subject 5 5 ±2 
 
 
4.3 EMG 
EMG data is presented as a percentage of MVC. In theory this parameter should 
be between 0 and 100%. EMG during transfer trials was typically greater than that 
recorded during the MVC trials, therefore % MVC values reported exceed 100%. 
Theoretically, a subject will exert the maximum force possible during the MVC trials and 
any data captured during the transfers will be of a lesser value. Percent MVC data for 
this study was not ideal however and therefore EMG data will still be presented as % 
MVC, but is not necessarily capped at 100%. 
EMG data for subject 1 will not be presented due to improper data collection.  
 
4.3.1 Wheelchair Transfers 
“Event” trials as stated earlier are those trials in which the left or right hand 
contacted a force transducer and generated a measureable force during a transfer. The 
beginning and end of an event was based on visual inspection from motion capture data, 
a digital video camera and graphical force data. 
All subjects were right hand dominant. All transfers to the vehicle seat from the 
wheelchair moved the subject from left to right; except for the Ryno Lift transfers. 
Subjects then moved from right to left on their way back to the wheelchair.  
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Each subject appeared to have difficulties with the transfer tasks. In a 
comparison of % MVC of subjects 2 through 5, subject 5 had the highest mean % MVC 
across all muscle groups (Figure 4.10). Subject 4 had the greatest variability across all 
muscle groups. Subject 3 was found to be significantly different than subjects 2, 4 and 5. 
 
 
Figure 4.10: % MVC “Event” Trials per Subject. 
 
% MVC averaged across all muscle groups compared muscle exertion per task 
(Figure 4.11). The average % MVC generated during the unassisted transfers was the 
highest amongst all the transfer tasks, showing that it required the most muscle exertion 
across all subjects, with the greatest variability across muscle groups and subjects. The 
average for the unassisted transfers is in fact double that of the transfer board, which 
required the next highest muscle exertion. The unassisted transfer was found to be 
statistically significantly different from the transfer board, Glide ‘n’ Go and Ryno Lift 
transfers. 
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Figure 4.11: % MVC “Event” Trials per Task. 
 
Figure 4.12 shows the average % MVC across all muscle groups is higher for the 
trailing arm versus the leading arm. There was no statistical difference found between 
the leading and trailing arms. 
 
 
Figure 4.12: % MVC Full Transfer Trials – Leading vs. Trailing Arm. 
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Figure 4.13 shows a comparison of each of the transfer tasks during a full 
transfer trial. These trials include data before, during and after the transfer from initial to 
target seat took place. The mean % MVC for the transfer board was found to be the 
highest with the unassisted transfer following. The Glide ‘n’ Go had the most variability 
between muscle groups, but had the lowest average % MVC overall. Two different 
statistically significant groups were found between the full transfers tasks. The transfer 
board and unassisted transfers were found to be significantly different from the Easy 
Reach and Ryno Lift transfers. The Glide ‘n’ Go transfer was found to not be significantly 
different from the other transfers. 
 
 
Figure 4.13: % MVC Full Transfer Trials per Task. 
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not defined for the stowage and removal trials because it was found that the more 
significant forces and moments occurred during the transfer trials. However, EMG data 
for these trials was analyzed. 
Figure 4.14 captures the difference in EMG activity between the car height and 
the truck height. The average % MVC of the raised height is ~1.8 times higher than that 
of the car height. In a 2-sided t-test the mean muscle exertion at the car height and truck 
height were found to be significantly different.  
 
 
Figure 4.14: % MVC Wheelchair Stowage per Height. 
 
 
4.4 Pain and Questionnaires  
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Table 4.7 breaks down the subject’s impression of the device used to perform the 
transfer. From this table it is seen that subjects were most comfortable with the Ryno Lift 
and transfer board. Overall the Ryno Lift received the highest scores based on comfort, 
ease of use, efficiency and safety, while the Easy Reach received the lowest score 
overall. From most favorable to least across all factors, assistive devices were rated: 
Ryno Lift, transfer board, Glide ‘n’ Go, Easy Reach. The “overall comfort” of the Ryno Lift 
was found to be significantly different from the Easy Reach and Glide ‘n’ Go. It was also 
found that perceived safety of the transfer board was found to be significantly different 
from the Easy Reach and Glide ‘n’ Go, while the Glide ‘n’ Go was found to be 
significantly different from the Ryno Lift and the Ryno Lift was found to be significantly 
different from the Easy Reach. 
 
Table 4.6: Pain Questionnaire. 
 
Table 4.7: Transfer Device Questionnaire. 
 
Scale: 0 – 10 Where 10 is the “worst pain ever” and 0 is “no pain” 
 
Mean St Dev 
Rate you usual level or pain during the past week. 3.1 1.3 
Rate your pain at its best during the past week. 0.25 0.50 
Rate your pain at its worst during the past week. 5.8 1.0 
Rate the current level of pain you are now experiencing based on the current transfer 
method: 
     Unassisted 1.4 1.5 
     Transfer Board 1.4 1.5 
     Glide ‘n’ Go 2.0 1.7 
     Ryno Lift 1.3 1.5 
     Easy Reach 1.4 1.5 
Scale: 0 – 5 Where 5 is “very good” and 0 is “very poor” 
 
Transfer Board Glide ‘n’ Go Ryno Lift Easy Reach 
How would you rate your overall comfort during the use of this product? 
Mean 
St Dev 
4.2 
1.3 
2.7 
0.6 
4.8 
0.5 
2.8 
1.3 
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Table 4.7 (continued) 
 
 
  
What is your impression of this product’s overall ease of use? 
Mean 
St Dev 
4.0 
1.2 
3.0 
1.0 
4.3 
1.0 
2.7 
1.2 
How efficient do you feel this product will be in use of your time? 
Mean 
St Dev 
4.2 
1.3 
3.3 
1.2 
4.3 
1.0 
3.0 
1.6 
How safe do you feel during use of this product? 
Mean 
St Dev 
4.6 
0.6 
3.0 
1.0 
4.8 
0.5 
2.3 
1.6 
Total 17.0 11.0 18.2 9.8 
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Chapter 5 – Discussion 
This study hypothesized that the use of an assistive device would eliminate some 
of the stresses posed on the UEs during wheelchair to vehicle transfers. It was also 
expected that these transfer events will generate high moments at the shoulders, which 
could be injurious over time.  
The Easy Reach was found to be the least favored of all the devices (Table 4.7: 
Transfer Device Questionnaire). This can be attributed to a number of factors: 
1. Subject’s inexperience with the device, 
2. Height at which the subject was raised during the transfer into the vehicle 
(although this height was not unlike that required for the Glide ‘n’ Go transfer),  
3. Appearance of instability of the device while being lowered, 
4. Lack of rigidity of the vehicle seat when it was in the lowered (transfer) position, 
5. Location of the transfer did not provide access to extra supports such as the 
steering wheel and grab handle.  
The Ryno Lift was ranked highest in all categories (comfort, ease of use, 
efficiency and safety). This may be attributed to the ease at which the subjects entered 
the vehicle, although this particular device played no actual role in the transfer itself as 
the device aided in placing subjects in the passenger area before performing the transfer 
to the vehicle seat. 
The transfer board was ranked second after the Ryno Lift, which is likely 
attributed to increased experience with this device as it is frequently introduced during 
rehabilitation after a spinal cord injury. 
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Transfers that utilized the transfer board and Easy Reach as well as the 
unassisted transfer were level transfers. The Glide ‘n’ Go mock-up and the Ryno Lift 
mock-up did not allow for level transfers. Previous research has determined that a level 
transfer is ideal.54 The height difference of these transfers was found to be significantly 
different (Figure 4.14).  
Differences between all joints of the right and left UEs are more varied in these 
non-level transfers. Table 5.1 shows the forces averaged across the joints of each UE 
for each transfer task. All subjects were right hand dominant, but that does not appear to 
correlate with the subject’s ability to comfortably transfer and even apply more body 
weight with the left hand. Researchers have found that preference of transfer side, 
whether it is in the dominant or non-dominant hand direction, does not have a significant 
effect on the ability or effort required to transfer in either direction.72 
From Table 5.1 it is seen that the Ryno Lift transfers had the greatest variance 
between the right and left arms with the Glide ‘n’ Go following. The forces generated by 
the left and right hands were found to be significantly different for the Glide ‘n’ Go and 
Ryno Lift transfers when a 2-sided t-test was conducted with the assumption of unequal 
means. 
 
Table 5.1: Max Force (N) per Transfer Task – Left Arm vs. Right Arm. 
 
Left UE Right UE Range 
Transfer Board 295 304 9 
Unassisted 488 468 20 
Glide ‘n’ Go 178 345 167 
Ryno Lift 434 201 233 
 
Transfers involving the Ryno Lift were typically led with the left UE. Figure 5.1 is 
a breakdown of all the Ryno Lift transfer “event” trials. This normalized data shows that 
subjects typically used the steering wheel to support their body weight during a transfer, 
but in one instance a subject utilized the grab handle. The forces generated at the grab 
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handle exceeded those seen at the steering wheel. There are two distinct groups 
(p≤0.0001), showing the differences between the loads applied by the left hand versus 
those applied by the right hand. Upon reviewing these trials again it was found that in the 
events in which the right hand generated force during a transfer, more of the subjects 
body weight was applied to another un-instrumented surface.  
 
 
Figure 5.1: Ryno Lift Transfers. Trials are defined by: subject, transfer into or 
out of vehicle and transducer to which force was applied. 
 
During testing it was found that a number of surfaces were used to assist in 
transferring, but were not instrumented and therefore not captured in this study. These 
surfaces included wheelchair armrests, wheelchair wheels, wheelchair seat, vehicle seat 
and the vehicle seat armrest.  
As part of the inclusion criteria subjects were required to regularly perform 
transfers, yet they were not all previously subjected to each of the assistive devices used 
during the study. Some subjects had notably more difficulty during the transfer trials than 
others, which appeared to also correlate with their BMI (Figure 5.2). Subject 2 who had 
the highest BMI of all subjects also had the most difficulty during all phases of the study. 
He was also the only subject who did not perform some sort of regular exercise or 
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participate in recreational activities. Researchers have found that regular activity affects 
transfer ability.33,47 
 
 
Figure 5.2: BMI vs. Number of Transfers Completed. 
 
While traumatic brain injury (TBI) is outside the scope of this study, subject 4 
reported suffering from a severe TBI at the time of his spinal cord injury. This was found 
to affect his cognitive function in the sense that it took him more time to process and 
complete all tasks. Yet it did not appear to interfere with his actual transfer ability. Figure 
4.9 and Table 4.5 (Number of Hand Positions per Subject) provide quantitative results 
for these observations. 
Figures 4.3 (Max Forces per Transfer Task), 4.4 (Mean Forces per Transfer 
Task) and 4.11 (% MVC “Event” Trials per Task), show that using a device, even one 
that is unfamiliar, can be beneficial in alleviating some of the stresses that are typically 
encountered at the UEs. In all cases, results for forces and EMG proved to be highest 
for the unassisted transfers. Based on observation alone it was typically seen that 
transfers requiring the use of an assistive device were less strenuous, even if the subject 
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had not previously used that device. In relation to difficulty of each task, it appeared to 
make no difference that the Ryno Lift and Glide ‘n’ Go were mock-ups.  
Some difficulty was observed during the trials requiring the use of the Ryno Lift. 
Challenges during these transfers were dictated more by the height differences between 
the initial and target seats as well as the distance from one seat to another and less due 
to the device itself. In some instances the Ryno Lift may be used to assist with getting 
into the vehicle, but require no transfer, as some may drive from their wheelchair once 
locked in place. Note: The VA does not condone driving from ones wheelchair, as 
wheelchairs do not meet the safety standards to which vehicle seats are subjected to 
uphold. 
Results show that overall the Glide ‘n’ Go generated the lowest forces and the 
lowest % MVC readings amongst all the devices. The transfer board proved to be the 
next best in terms of generating the lowest forces at the UEs during the transfer from 
initial to target seat. 
Statistical significance of tasks was different for the forces of the right and left 
UE. This can be attributed to a number of factors. First, non-level transfers cause 
asymmetry in the transfer task, generating unequal stresses at each of the UEs. 
Unequal stresses may also be seen in leading versus trailing arms. Secondly, in some 
cases it was found that a higher percent body weight was typically applied by one hand 
over the other (Figure 5.1). This was not an affect of hand dominance as all subjects 
were right hand dominant and in the case of the Ryno Lift, greater forces were applied 
by the left hand. Lastly, force data found that there was no statistical difference between 
the unassisted and Ryno Lift transfers or between the transfer board and Glide ‘n’ Go 
transfers. However, these two groups were found to be statistically significant from one 
another at all joints of the left UE. At the right UE the only statistical difference was found 
between the unassisted and Ryno Lift transfers. 
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Hand position when applying load during a transfer had an impact on the forces 
and moments that were generated. It was found that some of the highest forces were 
found at the handle. Based on observations, this result is expected since subjects were 
able to more easily pull up a greater percent of their body weight as opposed to applying 
a push force to the steering wheel. The vehicle door was utilized by only subject 1 for 
minimal load bearing during the transfers and was found to be one of the least stable 
locations for support. The steering wheel however was expected to generate some of 
the highest moments due to the angle of the shoulder at which the force was applied.  
Of all the joints of the UE, the shoulders appear to have the most sensitivity to 
force and position and also proved to be the most crucial joint in which to prevent injury 
and pain. This is largely seen in the amount of variability at this joint during the transfer 
trials. The greatest variability was seen at the left shoulder during the Ryno Lift transfers, 
which is an extension of the force results shown. While it was found that the unassisted 
transfers generated the highest forces, the lack of assistive device did not necessarily 
generate the highest moments.  
Figure 5.3 compares the left and right shoulders for each task. A significant 
difference between these 2 joints during the Ryno Lift transfers. 
 
Figure 5.3: Moments 
 
Moments generated during the unassisted trans
the elbow and wrist for both the left and right UEs. At the right and left shoulders the 
highest moments were frequently found at the steering wheel. Statistically significant 
differences between the steering wheel and othe
shoulders.   
Significant differences between the unassisted transfers and the transfer board, 
Glide ‘n’ Go and Ryno Lift transfers can be attributed to the extra challenge that was 
observed when subjects did not have ac
“Event” Trials per Task). While the primary goal of this study was to view the duration of 
the transfer tasks from initial to target seat, data was also captured prior to and post 
transfer. The unassisted and
Easy Reach and Ryno Lift transfers, which is evidence that some transfers require more 
effort than others before and after the actual transfer takes place. 
Complications surrounding the fact th
unsolved, but not without speculation as to why:
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1. MVC capture method. While the approach seemed logical and followed prior 
literature,86 it is possible that the method used during this study can be improved 
upon.  
2. Subject inconsistency. Subjects did not exert as much force during the MVC trials 
as they did during the wheelchair transfer and wheelchair stowage trials.  
3. EMG electrode contact. MVC trials were performed first allowing less time for 
electrode contact than for the other trials captured later. It is known that the 
longer the contact time for an EMG sensor, the greater chance there is for better 
contact due to perspiration and steadying of the signal. This leads to the 
conclusion that contact was better during the wheelchair transfer and wheelchair 
stowage trials.  
4. Muscle signal. During MVC trials muscle exertion was slow with a steady 
increase as seen in Figure 3.25 (MVC Calibration Filter Effect). This is in contrast 
to some of the EMG signals seen during the transfer trials, especially those 
which generated high peaks during more strenuous movements. 
 
The inclusion criteria had no requirement for subject to stow and remove their 
own wheelchairs. It was found that many of the subjects did not regularly stow their own 
wheelchairs. Based on observation alone wheelchair stowage appeared to be one of the 
more challenging aspects of data collection requiring trunk stability to help minimize 
forces at the shoulder, elbows and wrists.  
 Figure 5.4 shows the effect of transfer order on % MVC during an “event”. While 
there is seemingly a large difference between the means of tasks 1 and 2 this difference 
is not significant. The measure in this case is also misleading in that trials for task 1 were 
dominated by “events” that occurred during unassisted transfers. Unassisted transfers 
were previously shown to require the highest muscular exertion  
66 
Figure 5.5 shows the effect of transfer order on % MVC during the full transfer 
trials, which contained the entire transfer from initial to target seat as well as some data 
prior and post transfer. It was expected to see the trend evidenced in Figure 5.4, but 
there is actually a significant difference between task 1 and task 2, which had the next 
highest mean. Of transfers that were completed and able to be processed, the second 
task is only represented by the transfer board, which was previously shown during the 
full transfer trials to have required the highest muscular exertion. While EMG frequency 
decrease as muscles become fatigued, it cannot necessarily be said that this data 
provides any insight into fatigue that may occur from performing multiple transfers in 
sequence. 
 
 
Figure 5.4: % MVC “Event” Trials per Task Order. 
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Figure 5.5: % MVC Full Transfer Trials per Task Order. 
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Chapter 6 – Conclusions and Recommendations 
6.1 Conclusions 
It is well established in the literature that SPTs (sitting pivot transfers) are one of 
the most demanding of all wheelchair related ADLs6,51,52,67,90 and that of this type of 
transfer, vehicle transfers may be some of the most challenging. Prior to this study, there 
had been little attention paid to this important area of research. This study is a step 
forward in discovering how those with SCI can adapt as they age and are subjected to 
an increased risk of degenerative injuries, along with decreased recovery time and 
cumulative pain.  
 While many assistive devices are available, there is no measure concerning the 
effectiveness of these devices when it comes to comfort, efficiency and the feeling of 
safety. It is clear that there is a need for these types of devices simply based on the 
product market.  
 Ultimately this study found that using an assistive device is more effective than 
not using an assistive device. This is proven by EMG and force data, which were both 
found to be less with the use of an assistive device as, opposed to transferring 
independently with no assistance.  
 With this knowledge, a problem to overcome will be the stigma that comes with 
using an assistive device. Through conversation with the recruited male sample, it was 
found that many find the use of a device to make them less “macho” even if it is well 
known that using an assistive device can protect their UEs from injury and pain. 
While it is difficult to make sweeping conclusions that will apply to everyone with 
SCI, a few recommendations can be made from the results of this study. First it is 
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recommended based on observations and quantitative data, that those with SCI use 
some sort of assistive device when performing a transfer. This will help to maintain 
function of their UE over a longer period of time. Second, it is recommended that those 
with SCI typically perform level, or close to level transfers, such as to a car versus a 
truck. Assistive devices can likely be even more beneficial with training and practice. 
Lastly, it is recommended that those with SCI try to keep healthy through exercise and 
training and carefully manage their body mass. Staying fit will help to make transferring 
easier and alleviate any extra stresses due to body mass on the UEs. 
 
6.2 Limitations and Suggestions for Future Work 
Numerous challenges arose during the course of this study. As a learning 
experience these challenges were necessary and have provided insight for conducting 
future studies. 
 
6.2.1 Data Acquisition and Processing 
 Beginning with motion capture, insufficiencies were introduced into the data 
collection process. The smaller cross-sectional area of the frame of the vehicle model 
was a vast improvement over the previous version. Unfortunately there were still several 
issues that arose.  
During trials subjects occluded the markers with other areas of their body. This is 
unavoidable and was worse during the trials in which subjects were asked to stow and 
remove a wheelchair from the car. Even though the wheelchair was broken down, it was 
carried across the front of the body occluding many markers at once. There was also a 
problem of markers falling off during the trials. Markers that fell off were not replaced 
until the trial was completed. This was also the case for EMG electrodes, which due to 
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their location could not be wrapped to the body. Although with less frequency than 
markers, electrodes also lost contact. 
Camera placement may have also played a role in marker visibility. The motion 
capture system requires at least 2 cameras to resolve a marker. Placement of the 
vehicle was limited due to the lab’s arrangement and cameras were wall mounted, 
therefore data was not collected in the most ideal conditions.  
Marker occlusions led to difficultly in marker labeling, which created the need to 
view each trial and manually label all occluded markers in each frame. Trials ranged 
from ~1000 up to ~10,000 frames, with an average of about 3000 frames. This was a 
very time consuming process.  If a similar study is to be performed it is recommended 
that an active-marker motion capture system be used to completely eliminate the need 
for manual labeling. Additionally, for a study in which only the UEs are to be analyzed, 
no markers would be necessary for the lower extremities. 
Trials were performed only once due to time constraints, patient fatigue and risk 
of injury. Transfer-in and transfer-out trials were used as a 2 trial series for statistical 
purposes when possible. As seen in Table 4.1 even this was not always possible. 
 
6.2.2 Vehicle and Device Mock-up Designs 
 The mock-up designs and relative placement of devices was not completely 
accurate. This likely had no adverse effects on the study since all subjects used the 
same model, but design flaws are noted nonetheless. 
 The seat used in the vehicle was fairly low to the floor. This affected some of the 
transfer heights. Ideally all transfers would be level transfers. Level transfers put the 
least stress on the UE.54 
There were also some major design differences in the mock-up models as 
compared to the commercial devices. The most dissimilar being the Glide ‘n’ Go mock-
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up, which was very cumbersome and made stowing a wheelchair near impossible. 
Transfers to and from the Glide ‘n’ Go mock-up to the wheelchair were not level, but the 
actual device is designed to make all transfers level and does not create an extra 
obstacle when attempting to stow or remove a wheelchair.  
 
6.2.3 Recruitment and Testing 
 Subject recruitment was a significant weakness in this study. Recruiting in the 
SCI population posed a challenge and took approximately 18 months to obtain 5 
participants. VA Researchers are not allowed to solicit potential participants, therefore 
clinicians were asked to help. A modification was implemented later in the study, which 
allowed non-Veterans to also participate. Unfortunately, the proposed number of 
participants was not met, within an acceptable time frame. 
 It would have been beneficial to run multiple trials of each transfer task, but due 
to safety, fatigue and physical ability this was not possible. Some subjects were unable 
to perform all the tasks called for in the study, due to lack of ability, inexperience, body 
weight, and/or fatigue. 
 
6.2.4 Variability 
6.2.4.1 EMG 
 There was some variability in the EMG testing due to the fact that the 
researchers conducting data collection had no previous experience in EMG placement at 
the UE. Literature references were used to place electrodes as accurately as possible, 
but variability likely occurred between subjects and researchers. 
 Variability in EMG data also arose from having to replace sensors that lost 
contact during trials. After initial attachment of EMG sensors, the subject was asked to 
activate each muscle to assure proper contact. All sensors were then zeroed via 
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hardware and software. However, sensors were not zeroed or signal checked when 
replaced after loss of surface contact. The position of replaced electrodes was not found 
to be an issue since the skin was marked. Subjects were only asked to complete one 
MVC trial for each muscle group so as not to get fatigued prior to performing a series of 
transfers. With only one trial it is difficult to know the accuracy of the trial and may have 
been beneficial to conduct more than a single MVC trial. 
 
6.2.4.2 Participants 
 Any study involving human subjects will exhibit variability within the population. 
Some disparities that made an observational difference were subject BMI and cognitive 
health. Within the SCI population there is much variability in injury level, which greatly 
affects their physical ability. 
 
6.2.5 Future Work 
In continuation of this study a few changes should be introduced. The marker set 
would be limited to just the trunk and UE and an active motion capture system would be 
used rather than a passive one to eliminate the need for manual marker labeling while 
increasing accuracy.  
Many of the transfers that took place in this study were done for the first time by 
the subjects and were completed only once. With this limitation, it is difficult to know how 
well a person with SCI may perform if they had the opportunity to physically train with an 
assistive device. It could be hypothesized that there may be a learning curve associated 
with vehicle transfers and that over time the forces and moments acting on the joints of 
the UE could be minimized and muscle exertion decreased. 
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In the future studies related to wheelchair transfer can be expanded to include 
quadriplegics, as many are able to perform vehicle transfers and do so on a regular 
bases.  
Kinetics and kinematics are a good measure for comparison when relative to 
each other, but no research has been found that has addressed what, if any, significant 
magnitudes may lead to injury of the UE. What combination of forces, moments and 
angles may be considered injurious? 
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Appendix A – Informed Consent for an Adult Form 
 
University of South Florida, the IRB of record for the James A. Haley VA Hospital 
Information to Consider Before Taking Part in this Research Study 
 
IRB Study #___106564_______ 
 
Informed Consent to Participate in Research and Authorization to Collect, Use and 
Share your Health Information 
 
Doctors and researchers at James A. Haley VA Hospital study diseases and other health 
problems people may have.  Our goal is to try to find better ways to help treat these 
health problems.  To do this, we need the help of people who are willing to take part in a 
research study.  
 
We are asking you to take part in a research study that is called: 
Evaluation of Transfer Technologies to Preserve Shoulder Function in SCI 
 
The person who is in charge of this research study is Dr. John Lloyd.  This person is 
called the Principal Investigator.  However, other research staff may be involved and can 
act on behalf of the person in charge.  The person explaining the research to you may 
be someone other than the Principal Investigator.  Other research personnel who may 
be involved with you include: Kevin White, MD; Jeffrey Harrow, MD, PhD; Ron Gironda, 
Ph.D.; Steve Luther, Ph.D., Shawn Applegarth MSME, Ron Gironda, PhD, Shirley 
Fitzgerald PhD; Karen Mann, BSME; Mike Kerrigan, BSME and Ron Olney, PhD. 
 
The research will be done at the Patient Safety Center/James A. Haley V.A Hospital 
 
This research is being paid for by VA Rehabilitation Research and Development 
 
Should you take part in this study? 
This form tells you about this research study.  After reading through this form and having 
the research explained to you by someone conducting this research, you can decide if 
you want to take part in it.  You do not have to take part in this research to receive 
medical care.  Reading this form should help you decide if you want to take part in the 
study.  If, at any time, you have any questions, feel free to ask the person explaining this 
study to you. 
 
Before you decide: 
1. Read this form and make sure you know what the study is about. 
2. Talk about this study with the study doctor or the person explaining the study.  
You can have someone with you when you talk about the research study. 
 
This form explains: 
1. Why this study is being done. 
2. What will happen during this study and what you will need to do. 
3. Whether there is any chance you might experience potential benefits from being 
in this study.   
4. The risks of having problems because you are in this study. 
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You can ask questions: 
You may have questions this form does not answer.  If you do, ask the study doctor or 
study staff as you go along.  You don’t have to guess at things you don’t understand.  
Ask the people doing the study to explain things in a way you can understand. 
 
After you read this form, you can: 
1. Take your time to think about the information that has been provided to you.  
2. Have a friend or family member go over the form with you. 
3. Talk it over with your regular doctor. 
 
It’s up to you.  If you choose to be in the study, then you can sign the form.  If you do not 
want to take part in this study, you should not sign the form.   
 
Why is this research being done? 
The purpose of this study is to find out which wheelchair transfer device is easiest and 
safest for getting into and out of a vehicle. You will be asked to transfer in and out of a 
minivan and stow and retrieve a rigid wheelchair while using five commercially-available 
devices. 
 
Why are you being asked to take part? 
We are asking you to take part in this research study because you are treated at the 
Tampa VA for your spinal cord injury, are between the ages of 18 and 65 years, use a 
manual wheelchair, and transfer independently.    
 
How long will you be asked to stay in the study? 
Data collection, from start to finish, will last approximately 4 (four) hours. It may be on a 
single visit or in 2 visits, depending on scheduling needs of both the researchers and 
you. 
 
How often will you need to come for study visits? 
A research study visit is one you have with the study doctor or research personnel.  This 
visit is different than the visits you make with your regular doctor.  You will need to come 
for one study visit. The study visit will take about four hours.   
 
How many other people will take part? 
About 58 people will take part in this study at the Tampa VA.  
 
Will your regular medical treatment change if you take part in this study? 
The kind of medical treatment you now get from your regular doctor will not change 
because you take part in this study.  You will keep seeing your regular doctor.  Your 
regular doctor will give you the same kind of treatment you would get anyway, whether 
or not you take part in the study. 
If you need to, you can:  
1. Use medicines prescribed by your regular doctor.   
2. Have surgery you need. 
 
However, you should tell the study doctor about all the medicines you take and about 
any planned surgery you may have scheduled. 
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If you have an emergency, you can get emergency care.  If possible, let the emergency 
caregiver know that you are participating in a research study.  Also, let the study doctor 
know that you have had to seek emergency care as soon as possible. 
 
What other choices do you have if you decide not to take part? 
If you decide you do not want to take part in this study that is okay.   If you decide not to 
participate in this research, there are no other choices similar to this research and so 
your other choice would be not to participate, but you can continue to see your regular 
doctor for management of your condition or disease. 
 
How do you get started?  
If you decide to take part in this study, you begin by signing this consent form.  This form 
is also your agreement to allow us to use your personal health information as needed in 
the research study. Until you have agreed to take part in the study and have signed this 
form, no research actions or measures will take place.   
 
If you decide to take part in the study, we will do a screening test. Screening tests are 
done to see if you are able to be in the study. 
 
The following are screening tests: 
3. The screening test will consist of a physical evaluation to determine if your range 
of motion and strength of shoulder, elbow and wrist are relatively equal. The 
screening test will take about five minutes and we will immediately know the 
results of this test and whether or not you should be in the study.   
 
What will you need to do to get ready for this study? 
To begin the study, you will need to bring or wear athletic shorts and a T-shirt.  
 
What will happen during this study? 
 
Your study visit will consist of the following: 
A board certified SCI physician and an Ergonomist/Biomechanist will review your 
medical chart and perform a physical evaluation to make sure you can participate in this 
study.   After the evaluation, you may be asked to return on another day for the testing, 
or you may go straight to testing, depending on the scheduling of both the researchers 
and you. 
 
Next you will be shown how to use the different devices and asked to practice each step 
of the transfers, which involves transferring into the vehicle’s driver’s seat, stowing a 
manual chair in the passenger compartment, retrieving the wheelchair from the 
passenger compartment, then transferring from the vehicle to wheelchair.   
 
When ready, we will gather information about how you transfer and what effect this has 
on your upper-body will be collected using a motion analysis system. You will need to 
dress in athletic shorts and T-shirt for this part of the study because a series of markers 
will be placed on your body using adhesive tape. After the makers are placed, we will 
also attach electrodes to the surface of your skin to capture the muscle activity during 
the transfer. You will also be asked to wear gloves during the transfer so we can 
measure the forces you exert with your hands.   
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We would like to video-tape and take still pictures of the testing to help us see how you 
conduct the transfers. 
 
You will be shown a video of someone performing each transfer so that you know what it 
looks like. You will be asked to perform each of the five transfer tasks. Rest periods will 
be allowed as needed. After each transfer, a team member will ask you questions about 
how you feel, and what you thought about the different transfer devices. Once 
completed, we will remove the markers, electrodes and gloves. The data collection and 
the medical testing should take no more than 4 hours.  
 
Will you be paid for taking part in this study? 
We will pay you $75 for your time and transportation costs for being in this study.  
 
What will it cost you to take part in this study? 
It will not cost you anything to be part of the study.  
 
If you are a VA patient, there may be co-payment costs for some of the procedures that 
occur during the research for which the VA may not pay.  Some veterans are required to 
pay co-payments for medical care and services provided by the VA.  These co-payment 
requirements will continue to apply to medical care and services provided by the VA that 
are not part of this study. 
 
What are the potential benefits if you take part in this study? 
We do not know if you will get any health benefits by taking part in this study.  We do not 
know if this study will help spinal cord injury users with their transfers in and out of a car.  
 
That is why we are doing this study.  This research study should help us learn more 
about which assistive device will help prevent injuries.  
 
What are the risks if you take part in this study? 
 
The treatment might not help. 
There is a possibility that you could become anxious, frustrated or otherwise upset 
during the evaluation sessions if you think that you are not performing as well as you 
expect. These feelings should be relatively brief and you will receive feedback about 
your performance when testing has been completed. It is possible that you may 
experience a wheelchair tip, fall, or upper extremity discomfort while you are performing 
the wheelchair transfers.  
 
There may be side effects. 
You may also discover some bruising or soreness from exertion after the testing is 
completed. We will monitor you carefully to avoid these adverse events. 
 
There is always a chance that any medical treatment may cause you some discomfort or 
harm and the procedures in this study are no different.  We will do everything possible to 
keep you from being harmed.  There may be other risks or side effects that occur which 
we do not know about at this time.  It is important for you to tell us when you experience 
such a side effect. 
 
87 
Appendix A (continued) 
 
If you have any of these problems, tell the study doctor.  If these side effects bother or 
worry you, or if you have other problems, call John Lloyd at (813) 558-3925 or Ron 
Olney at (813) 558-3968.  It is uncommon for the medical treatment that you would 
receive as your standard care to also cause problems.   
 
What if you get sick or hurt while you are in the study?  
You are participating in a research project approved by a Research and Development 
Committee and conducted under the supervision of one or more VA employees. If you 
are injured because of your participation as a research subject in this research study, the 
VA medical facility will provide you with necessary medical treatment.   
 
If you need emergency care: 
4. Go to your nearest hospital or emergency room right away. Call 911 for 
help.  It is important that you tell the doctors at the hospital or emergency 
room that you are participating in a research study. If possible, take a copy of 
the consent form with you when you go. 
 
Call the study doctors as soon as you can.  They will need to know that you 
are hurt or ill.  Call Dr. John Lloyd at 813-558-3925 or Dr. Ron Olney at (813) 
558-3968. In case of emergency, please report to the nearest hospital, 
emergency room, and contact your family doctor. 
 
If you need emergency care in a private hospital, have a friend or family member contact 
the VA immediately at (813) 972-7037; and your study doctor so that they can 
coordinate care with a private hospital. If an eligible veteran requires admission to a non-
VA hospital as a result of an emergency, the Department of Veterans Affairs will not be 
responsible for the cost incurred unless the Department of Veterans Affairs is involved 
immediately.  
 
If you do NOT need emergency care: 
5. Go to your regular doctor.  It is important that you tell your regular doctor that you 
are participating in a research study. If possible, take a copy of this consent 
form with you when you go. 
 
If you are harmed while taking part in the study: 
If you believe you have been hurt or become sick because of something that is done 
during the study, you should call Dr. John Lloyd at 813-558-3925 immediately. 
 
What happens if you decide not to take part in this study? 
You should only take part in this study if you want to volunteer.  You should not feel that 
there is any pressure to take part in the study to please the study doctor or the research 
staff. 
 
If you decide not to take part: 
1. You will not be in trouble or lose any rights you normally have.  
2. You will still have the same health care benefits. 
3. You can still get your regular treatments from your regular doctor. 
 
What if you join the study and decide you want to stop later on? 
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You can decide after signing this informed consent document that you no longer want to 
take part in this study.  If you decide you want to stop taking part in the study, tell the 
study staff as soon as you can. 
• We will tell you how to stop safely.  We will tell you if there are any dangers if you 
stop suddenly. 
• If you decide to stop, you can continue getting care from your regular doctor.  
Are there reasons we might take you out of the study later on? 
Even if you want to stay in the study, there may be reasons we will need to take you out 
of it.  You may be taken out of this study if: 
1. We find out it is not safe for you to stay in the study.  For example, your health 
may worsen or we may find that transferring in and out of the vehicle might harm 
you.   
2. You are not coming for your study visits as scheduled. 
 
Authorization for Release of Your Health Information for Research Purposes 
Who will see the information that you give? 
In our research, we use and share information about people and their health.  We know 
that this information is private.  Federal law protects health information. 
 
The law lets us use and share health information for research if you agree to let us do 
this.  If you let us use and share information about you, we will protect it as required by 
law.  
 
If you sign this form, it means you are letting us use and share this information for 
research. 
 
Who will disclose (share), receive, and/or use your information? 
To do this research, James A. Haley VA Hospital and the people and organizations 
listed below may use or share your information.  They may only use and share your 
information: 
1. With the people and organizations on this list. 
2. With you or your personal representative. 
3. As allowed by law. 
 
James A. Haley VA Hospital and the people and organizations listed below may use or 
share information about you to do this research: 
1. The medical staff who are taking care of you. 
2. The research team, including the Principal Investigator, study coordinator, 
research nurses, and all other research staff.  Research staff may include the KT, 
the wheelchair consultant, the biomechanist, the engineer and the study 
physician.   
3. All health care and other James A. Haley VA Hospital staff who treat and serve 
you as a part of this research.  
4. Every research site for this study.  This includes the research and medical staff at 
each site and James A. Haley VA Hospital. 
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1. Any agency of the federal, state, or local government that regulates this 
research.  This includes the Food and Drug Administration (FDA), Florida 
Department of Health, and the Department of Health and Human Services 
(DHHS)  
2. The USF Institutional Review Board and its related staff who have oversight 
responsibilities for this study. 
3. The designated peer review committees such as: Protocol Review and 
Monitoring Committee; Data and Safety Monitoring Board; VA Research Services  
4. Data Managers  
 
The organizations and people listed above may employ or pay various consultants and 
companies to help them understand, analyze, and conduct this study.  All of these 
people may not be known now, but if you would like to have that information at any time 
during the study, you may ask the study doctor and you will be provided that information. 
 
Who else can use and share this information? 
Certain people may need to see your study records. By law, anyone who looks at your 
records must keep them completely confidential. 
 
Once any information leaves James A. Haley VA Hospital, we cannot promise that 
others will keep it private.  James A. Haley VA Hospital cannot stop others from using or 
sharing information they have about you.  The sponsor may share your information.  If 
the sponsor or others share your information, your information may no longer be 
protected by federal privacy laws. 
 
What information will be used or shared? 
Others not listed here may be able to get information about you from those listed above.  
That is only allowed when the law does not require them to keep your information 
private. 
 
By signing this form, you are letting James A. Haley VA Hospital collect, use, and share 
the following information:   
1. Your whole research record 
2. All of your medical and other records held by James A. Haley VA Hospital. 
This includes, but is not limited to, biomechanical data, information on 
muscle activity, and data from questionnaires. 
 
By signing this form, you are giving your permission to use and/or disclose your 
protected health information as described above. Your authorization to use your health 
information will not expire until the end of this research study unless you revoke that 
authorization in writing. 
 
Your Rights: 
You can refuse to sign this form.  If you do not sign this form: 
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1. You will not be able to take part in this research and therefore not be able to receive 
the research study drug or procedure.  However, you can receive other 
procedures that are currently available for your spinal cord injury as part of your 
regular medical treatment 
2. This will not change your health care outside of this study. 
3. This will not change your health care benefits. 
4. This will not change the costs of your health care. 
 
You can revoke this form at any time.  This means you can tell James A. Haley VA 
Hospital to stop using and sharing your information.  If you revoke this form: 
1. We will stop collecting information about you.  
2. The information that we have collected before you tell us to stop may 
already have been used or shared, or we may need it to complete the 
research so you cannot withdraw that information. 
3.  Staff may follow-up with you if there is a medical reason to do so. 
 
To revoke this form, you must tell us in writing.  To revoke your authorization, you must 
write to the Release of Information Office at this facility or you can ask a member of the 
research team to give you a form to revoke the authorization. Your request will be valid 
when the Release of Information Office receives it. If you revoke this authorization, you 
will not be able to continue to participate in the study. 
 
If you revoke this authorization, your research doctor or staff can continue to use 
information about you that was collected before receipt of the revocation. The research 
team will not collect information about you after you revoke the authorization. 
 
While we are doing this research, we cannot let you see or copy the research 
information we have about you.  After the research is done you have a right to see and 
copy the information about you, as allowed by James A. Haley VA Hospital policies. 
 
The VHA complies with the requirements of the Health Insurance Portability and 
Accountability Act of 1996 and its privacy regulations and all other applicable laws that 
protect your privacy.  We will protect your information according to these laws.  Despite 
these protections, there is a possibility that your information  
 
could be used or disclosed in a way that it will no longer be protected.  Our Notice of 
Privacy Practices (a separate document) provides more information on how we protect 
your information.  If you do not have a copy of the Notice, the research team will provide 
one to you. 
 
What will we do to keep your study records private and confidential? 
There are federal laws that say we must keep your study records private.  We will keep 
the records of this study private and confidential by retaining them in a secure building in 
locked files. All computer data will be encrypted to protect patient confidentiality and 
saved on VA ISO approved secured computer systems. Any electronic transmission will 
use PKI. Data will be maintained and destroyed in accordance with the VA record control 
schedule. 
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We may publish what we learn from this study.  If we do, we will not let anyone know 
your name.  We will not publish anything else that would let people know who you are. 
 
You can get the answers to your questions, concerns, complaints or issues. 
If you have any questions, concerns, complaints or issues about this study, call Dr. John 
Lloyd at (813) 558-3925. 
 
If you have questions about your rights as a person taking part in this study, call the 
Division of Research Integrity and Compliance of the University of South Florida at (813) 
974-9343. 
 
If you would like to contact someone independent of the research study, or cannot reach 
the research staff, you may contact the James A. Haley VA Hospital Research 
Compliance Officer at (813) 972-2000 ext. 7872. 
  
Statement of Participation in Research and Authorization for the Collection, use 
and Disclosure of Health Information 
It is up to you to decide whether you want to take part in this study.  If you want to take 
part, please read the statements below and sign the form if the statements are true. 
 
I freely give my consent to take part in this study and authorize that my health 
information as agreed above, be used/disclosed in this study.  I understand that by 
signing this form I am agreeing to take part in research.  I have received a copy of this 
form to take with me. 
 
             
Signature of Person Taking Part in Study    Date/Time 
 
        
Printed Name of Person Taking Part in Study 
 
      
Signature of Witness (must not be affiliated with the study team) Date/Time 
 
          
Printed Name of Witness 
 
 
Statement of Person Obtaining Informed Consent / Research Authorization 
I have carefully explained to the person taking part in the study what he or she can 
expect. 
 
I hereby certify that when this person signs this form, to the best of my knowledge, he or 
she understands: 
1. What the study is about. 
2. What procedures/interventions/investigational drugs or devices will be used. 
3. What the potential benefits might be.  
4. What the known risks might be.   
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I also certify that he or she does not have any problems that could make it hard to 
understand what it means to take part in this research.  This person speaks the 
language that was used to explain this research. 
 
This person reads well enough to understand this form or, if not, this person is able to 
hear and understand when the form is read to him or her. 
 
This person does not have a medical/psychological problem that would compromise 
comprehension and therefore makes it hard to understand what is being explained and 
can, therefore, give informed consent.   
 
This person is not taking drugs that may cloud their judgment or make it hard to 
understand what is being explained and can, therefore, give informed consent.   
 
 
             
Signature of Person Obtaining Informed Consent   Date/Time 
 
 
          ____________ 
Printed Name of Person Obtaining Informed Consent               Date/Time 
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SUBJECT# _____       DATE: __________ 
 
Physician Evaluation Acceptable Unacceptable 
Informed Consent 
  
MEDICAL CHART REVIEW: 
  Age 
   
  Level of injury  
  (ASIA A T2 through L5) 
   
  Duration since injury  
   
  BMI 
   
  Cardiac / Respiratory impairment 
  
  Evidence of current or recent UE injury / disorder 
  
  Other disease or unstable medical condition, including 
pregnancy 
  
  Has not been on extended bed-rest in last month 
  
OBSERVATIONAL EVALUATION 
  
  Upper extremity range of motion – similarity between 
left & right 
  
  Upper extremity strength – similarity between left & 
right 
  
  Uses manual vs. power chair for mobility 
  
  Is not ventilator dependent 
  
  Make / Model of patient’s wheelchair 
 
  Transfer method / technology typically used by the 
patient 
 
 
After evaluating the subject’s history and pertinent 
physical findings, this subject may safely participate in 
the wheelchair transfer study. 
Signature of physician: 
 
 
Subject not recommended for participation. 
Reason: 
 
Signature of physician: 
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– Physical Subscale) 
 
 
SUBJECT# _____ 
 
 
Here are some of the things which other patients have told us about their pain. For each 
statement, please circle any number from 0 to 4 (or not applicable) to indicate how much 
physical activities affect or would affect your upper extremity pain. 
 
 
 
Completely 
Disagree 
Unsure Completely Agree I Don’t 
Have 
Pain 
1. Physical activity 
makes my pain 
worse 
 
0 1 2 3 4 N/A 
2. Physical activity 
might harm me 
 
0 1 2 3 4 N/A 
3. I should not do 
physical activities 
which (might) make 
my pain worse 
 
0 1 2 3 4 N/A 
4. I cannot do 
physical activities 
which (might) make 
my pain worse 
 
0 1 2 3 4 N/A 
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SUBJECT# _____ 
 
Please consider any pain you have experienced in your shoulders, arms, elbows, wrists, 
or hands when answering the following questions. 
 
A.  On the following scale where 0= “No Pain” to 10= “Worst Pain Ever”, please circle 
the appropriate number to indicate how you would rate yourself in the following 
areas: 
 
  No Pain         Worst Pain Ever 
 
Rate the CURRENT LEVEL OF 
PAIN you are now experiencing 
0 1 2 3 4 5 6 7 8 9 10 
 
 
Rate your USUAL LEVEL OF 
PAIN during the PAST WEEK 
0 1 2 3 4 5 6 7 8 9 10 
 
 
Rate your pain at its BEST 
during the PAST WEEK 
0 1 2 3 4 5 6 7 8 9 10 
 
 
Rate your pain at its WORST 
during the PAST WEEK 
0 1 2 3 4 5 6 7 8 9 10 
 
 
B. On the following scale from “pain rarely interferes” to “pain always interferes”, please 
make a mark along the horizontal line to indicate how you would rate yourself in the 
following areas: 
 
  Pain Rarely 
Interferes         
Pain Always 
Interferes 
 
Rate how your current level of 
pain limits your ABILITY TO 
PROPEL your wheelchair 
______________________________________________ 
 
Rate how the current pain 
limits your ABILITY TO 
TRANSFER in and out of 
your wheelchair 
______________________________________________ 
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SUBJECT# _____ 
 
Product I.D: __________________ 
 
Examine the product very carefully and answer the following questions as they relate 
ONLY to this product.  
 
Please answer each of the following questions on a scale from 0 to 5, by circling the 
number that matches your impression, where 0 indicates very poor and 5 indicates very 
good. 
 
 
1. How would you rate your OVERALL COMFORT during use of this product? 
 
 
0   1   2   3   4   5 
 
 
 
1. What is your impression of this product’s OVERALL EASE-OF-USE? 
 
 
0   1   2   3   4   5 
 
 
 
1. How EFFICIENT do you feel this product will be in use of your TIME 
 
 
0   1   2   3   4   5 
 
 
 
1.  How SAFE do you feel during USE of this product? 
 
 
0   1   2   3   4   5 
 
 
Investigator notation as to method of transfer: 
_____________________________________________ 
 
  
Very 
Poor 
Very 
Good 
Average 
Very 
Poor 
Very 
Good 
Average 
Very 
Poor 
Very 
Good 
Average 
Very 
Poor 
Very 
Good 
Average 
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F.1 Kinetics 
 The following graphs and tables are supplemental information of the kinetics 
data. This data shows the magnitudes of the forces and moments with a table of the 
value of each data point. 
 
 
Figure F.1: Max Forces per Transfer Task 
 
Table F.1: Max Forces (N) per Transfer Task 
 
Left 
Shoulder 
Left 
Elbow 
Left 
Wrist 
Right 
Shoulder 
Right 
Elbow 
Right 
Wrist 
Transfer 
Board 
292 
(94) 
295 
(104) 
299 
(108) 
300  
(129) 
303 
 (130) 
308 
(133) 
Unassisted 471 (69) 
491  
(72) 
501 
(74) 
462 
(109) 
468  
(118) 
475 
(117) 
Glide 'n' Go 179 175 181 343 (103) 
345  
(112) 
348 
(118) 
Ryno Lift 437 (69) 
432 
(68) 
432 
(68) 
210 
(159) 
197  
(134) 
196 
(114) 
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 Statistically significant differences were found at the left UE. For the left shoulder, 
elbow and wrist the Ryno Lift and unassisted transfers were found to be different from 
the transfer board and Glide ‘n’ Go transfers. 
 
 
Figure F.2: Mean Forces per Transfer Task 
 
Table F.2: Mean Forces (N) per Transfer Task 
 
Left 
Shoulder 
Left 
Elbow 
Left  
Wrist 
Right 
Shoulder 
Right 
Elbow 
Right 
Wrist 
Transfer 
Board 
106 
 (21) 
105 
(19) 
108 
(19) 
126  
(93) 
129  
(98) 
134 
(98) 
Unassisted 190 (5) 
196 
(2) 
203 
(2) 
204 
(25) 
209 
(20) 
211  
(11) 
Glide 'n' Go 64 55 53 143 (53) 
143 
(52) 
140  
(42) 
Ryno Lift 165 (30) 
162 
(30) 
163 
(31) 
115 
(77) 
105 
(70) 
102 
(66) 
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Figure F.3: Max Moments per Transfer Task 
 
 
Table F.3: Max Moments (Nmm) per Transfer Task 
 
Left 
Shoulder 
Left 
Elbow 
Left  
Wrist 
Right 
Shoulder 
Right 
Elbow 
Right 
Wrist 
Transfer 
Board 
86653 
(46101) 
88702 
(37345) 
22515 
(14332) 
86934 
(38486) 
86425 
(37969) 
14970 
(6636) 
Unassisted 49705 (21925) 
122875 
(29493) 
22686 
(4182) 
81155 
(30012) 
126215 
(44345) 
57008 
(67661) 
Glide 'n' Go 45666 42075 7416 75967 (53123) 
92781 
(40855) 
17408 
(6203.9) 
Ryno Lift 192068 (80940) 
127787 
(28245) 
20713 
(3182) 
60307 
(29895) 
48923 
(33766) 
10476 
(6493) 
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Appendix F (continued) 
 
 Statistically significant differences were found at the left UE. For the left elbow 
the Glide ‘n’ Go transfer was found to be different than the unassisted trasnfer. At the left 
wrist the unassisted transfer was found to be different from the Glide ‘n’ Go and transfer 
board transfers. The Glide ‘n’ Go was also found to be different from the Ryno Lift 
transfer. 
 
 
Figure F.4: Mean Moments per Transfer Task 
 
 
Table F.4: Mean Moments (Nmm) per Transfer Task 
 
Left 
Shoulder 
Left 
Elbow 
Left 
Wrist 
Right 
Shoulder 
Right 
Elbow 
Right 
Wrist 
Transfer 
Board 
32261 
(14908) 
28174 
(6667) 
5005 
(1132) 
25264 
(3672) 
34325 
(27561) 
6198 
(4440) 
Unassisted 19771 (588) 
48961 
(3973) 
8871 
(436) 
27327 
(6022) 
52014 
(6875) 
9915 
(811) 
Glide 'n' Go 14955 11303 1905 28682 (12151) 
36629 
(16419) 
6939 
(2345.9) 
Ryno Lift 67936 (33288) 
44545 
(14027) 
6946 
(1013) 
37061 
(21372) 
26916 
(23633) 
5179 
(4206) 
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Appendix F (continued) 
 
 Statistically significant differences were found at the left UE. For the left shoulder 
the steering wheel was found to different from the grab handle and vehicle door. At the 
left elbow the grab handle was found to be different from the the vehicle door. 
 
 
Figure F.5: Max Moments per Transducer Location 
 
 
Table F.5: Max Moments (Nmm) per Transducer Location 
 
Left 
Shoulder 
Left 
Elbow 
Left  
Wrist 
Right 
Shoulder 
Right 
Elbow 
Right 
Wrist 
Door 12154 (572) 
41089 
(12329) 
7671 
(1091)    
Handle 50361 (13063) 
128045 
(18383) 
22254 
(2514) 
63317 
(24081) 
124617 
(37773) 
45306 
(76983) 
Wheel 167643 (72099) 
92158 
(45387) 
18825 
(12117) 
104348 
(39994) 
62964 
(20637) 
11067 
(3453) 
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Appendix F (continued) 
 
 Statistically significant differences were found at the left UE. For the left shoulder 
the steering wheel was found to different from the grab handle and vehicle door. At the 
left elbow and left wrist the grab handle was found to be different from the the vehicle 
door. 
 
 
Figure F.6: Mean Moments per Transducer Location 
 
 
Table F.6: Mean Moments (Nmm) per Transducer Location 
 
Left 
Shoulder 
Left 
Elbow Left Wrist 
Right 
Shoulder 
Right 
Elbow 
Right 
Wrist 
Door 6170 (487) 
9176 
(2557) 
1604 
(401)    
Handle 19350 (2009) 
40719 
(7673) 
7535 
(1559) 
26077 
(7628) 
53982 
(19993) 
10026 
(3159) 
Wheel 58079 (29563) 
33322 
(17659) 
5161 
(2108) 
32169 
(11612) 
20859 
(10987) 
3825 
(2083) 
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